EXHIBIT 1


                           STOCK PURCHASE AGREEMENT

                                 BY AND AMONG

                           RESPONSE ONCOLOGY, INC.,

       STOCKHOLDERS OF ONCOLOGY HEMATOLOGY GROUP OF SOUTH FLORIDA, P.A.

                                    AND

             SOUTH FLORIDA ONCOLOGY HEMATOLOGY ASSOCIATES, P.A.



                             December 20, 1995



                         STOCK PURCHASE AGREEMENT

     THIS STOCK PURCHASE AGREEMENT, dated as of December 20, 1995, by and among 
RESPONSE ONCOLOGY, INC, a Tennessee corporation (the "Purchaser"), the 
STOCKHOLDERS OF ONCOLOGY HEMATOLOGY GROUP OF SOUTH FLORIDA, P.A., each of whom, 
together with his or her state of residence and address, is listed on Exhibit A 
hereto (collectively, the "Sellers" and, individually, a "Seller") and SOUTH 
FLORIDA ONCOLOGY HEMATOLOGY ASSOCIATES, P.A., a Florida professional 
association (the "Group").

                            W I T N E S S E T H:

     WHEREAS, the Sellers own in the aggregate eighty (80) shares (the 
"Shares") of the common stock, par value $1.00 per share, of Oncology 
Hematology Group of South Florida, P.A., a Florida professional association 
engaged in the practice of medicine (the "Association"), with each Seller 
owning ten (10) Shares; and

     WHEREAS, the Sellers desire to sell and Purchaser desires to purchase the 
Shares on the terms and subject to the conditions set forth herein;

     NOW, THEREFORE, in consideration of the mutual covenants, representations, 
warranties and promises herein contained, and for other good and valuable 
consideration, the receipt and sufficiency of which are hereby acknowledged, 
the parties hereto agree as follows:


     1.     DEFINITIONS.  The following terms, as used herein, have the 
following meanings:
 
     "Adverse Consequences" means all actions, suits, proceedings, hearings, 
investigations, charges, complaints, claims, demands, injunctions, judgments, 
orders, decrees, rulings, damages, dues, penalties, fines, costs, amounts paid 
in settlement, Liabilities, obligations, Taxes, liens, losses, expenses, and 
fees, including court costs and attorneys' fees and expenses which, in the 
aggregate, would have a material adverse effect on the financial condition or 
results of operations of the Purchaser.

     "Affiliate" has the meaning set forth in Rule 12-2 of the regulations 
promulgated under the Securities Exchange Act.

     "Affiliated Group" means any affiliated group within the meaning of Code 
Section 1504 or any similar group defined under a similar provision of state, 
local or foreign law.

     "Agreement among Sellers" means an agreement, effective as of a time prior 
to the execution and delivery of this Agreement, pursuant to which the Sellers 
appoint an attorney-in-fact to execute and deliver this Agreement, collect the 
cash portion of the Purchase Price, take delivery of the Long-term Note and the 
Warrants, receive payments under the Long-Term Note, exercise Warrants and 
otherwise act on behalf of the Sellers for all purposes connected with the 
performance of this Agreement.

     "Applicable Rate" means the corporate base rate of interest announced from 
time to time by First Tennessee Bank National Association, Memphis, Tennessee 
plus two percent (2%).

     "Association" has the meaning set forth in the first recital above.

     "Base Purchase Price" has the meaning set forth in Section 2(a) below.

     "Basis" means any past or present fact, situation, circumstance, status, 
condition, activity, practice, plan, occurrence, event, incident, action, 
failure to act, or transaction of which any Seller has Knowledge that forms or 
could form the basis for any specified consequence.

     "Closing" has the meaning set forth in  Section 2(c) below.

     "Closing Date" has the meaning set forth in Section 2(c) below.

     "Code" means the Internal Revenue Code of 1986, as amended.

     "Controlled Group of Corporations" has the meaning set forth in Code 
Section 1563.

     "Deferred Intercompany Transaction" has the meaning set forth in Treasury 
Regulation 1.1502-13.

     "Deferred Purchase Price" has the meaning set forth in Section 2(b) below.

     "Employee Benefit Plan" means any (a) nonqualified deferred compensation 
or retirement plan or arrangement which is an Employee Pension Benefit Plan, 
(b) qualified defined contribution retirement plan or arrangement which is an 
Employee Pension Benefit Plan, (c) qualified defined benefit retirement plan or 
arrangement which is an Employee Pension Benefit Plan (including any 
Multiemployer Plan), or (d) Employee Welfare Benefit Plan or material fringe 
benefit plan or program.

     "Employee Pension Benefit Plan" has the meaning set forth in ERISA Section 
3(2).

     "Employee Welfare Benefit Plan" has the meaning set forth in ERISA Section 
3(1).

     "Environmental, Health, and Safety Laws" means the Comprehensive 
Environmental Response, Compensation and Liability Act of 1980, the Resource 
Conservation and Recovery Act of 1976, the Occupational Safety and Health Act 
of 1970, the Medical Waste Tracking Act of 1988, the U. S. Public Vessel 
Medical Waste Anti-Dumping Act of 1988, the Marine Protection, Research and 
Sanctuaries Act and Human Services, National Institute for Occupational Safety 
and Health, Infections Waste Disposal Guidelines, Publication No. 88-119, each 
as amended, together with all other laws (including rules, regulations, codes, 
plans, injunctions, judgments, orders, decrees, rulings, and charges 
thereunder) of federal, state, local, and foreign governments (and all agencies 
thereof) concerning pollution or protection of the environment, public health 
and safety, or employee health and safety, including laws relating to 
emissions,  discharges, releases, or threatened releases of medical wastes, 
pollutants, contaminants, or chemical, industrial, hazardous, or toxic 
materials or wastes into ambient air, surface water, ground water, or lands or 
otherwise relating to the manufacture, processing, distribution, use, 
treatment, storage, disposal, transport, or handling of pollutants, 
contaminants, or chemical, industrial, hazardous, or toxic materials or wastes.

     "ERISA" means the Employee Retirement Income Security Act of 1974, as 
amended.

     "Excess Loss Account" has the meaning set forth in Treasury Regulation 
1.1502-19.

     "Extremely Hazardous Substance" has the meaning set forth in Section 302 
of the Emergency Planning and Community Right-to-Know Act of 1986, as amended.

     "Fiduciary" has the meaning set forth in ERISA Sec. 3(21).

     "Financial Statement" has the meaning set forth in Section 4(g) below.

     "GAAP" means United States generally accepted accounting principles as in 
effect from time to time.

     "Group" has the meaning set forth in the initial paragraph of this Stock 
Purchase Agreement.

     "Knowledge" means actual knowledge after reasonable investigation.

     "Liability" means any liability (whether known or unknown, asserted or 
unasserted, absolute or contingent, accrued or unaccrued, liquidated or 
unliquidated, and whether due or to become due), including any liability for 
Taxes.

     "Long-Term Note" means the promissory note of the Purchaser payable to the 
order of the Sellers in the form set forth as Exhibit 2(b)(i).

     "Most Recent Balance Sheet" means the balance sheet contained within the 
Most Recent Financial Statements.

     "Most Recent Financial Statements" has the meaning set forth in Section 
4(f) below.

     "Most Recent Fiscal Month End" has the meaning set forth in Section 4(f) 
below.

     "Most Recent Fiscal Year End" has the meaning set forth in Section 4(f) 
below.

     "Multiemployer Plan" has the meaning set forth in ERISA Sec. 3(37).

     "Ordinary Course of Business" means the ordinary course of business 
consistent with past custom and practice. 

     "Party" means the Purchaser or any Seller.

     "PBGC" means the Pension Benefit Guaranty Corporation.

     "Person" means an individual, a partnership, a corporation, an 
association, a joint stock company, a limited liability company, a trust, a 
joint venture, an unincorporated organization, or a governmental entity (or any 
department, agency, or political subdivision thereof).

     "Prohibited Transaction" has the meaning set forth in ERISA Sec. 406 and 
Code Sec. 4975.

     "Pro Rata" means, with respect to the Sellers, their proportionate 
ownership interests in the Association.

     "Purchaser" has the meaning set forth in the initial paragraph of this 
Stock Purchase Agreement and, after Closing (and as relates to Section 9(b) 
regarding indemnification), shall mean Response Oncology, Inc. and any 
subsidiary or affiliate thereof.

     "Purchaser's Disclosure Letter" has the meaning set forth in Section 3(b) 
below.

     "Receivables" means the face amount, in dollars, of the Association's 
accounts receivable as of the close of business on the day prior to the Closing 
Date.

     "Reportable Event" has the meaning set forth in ERISA Sec. 4043.

     "Response Stock" means the common stock of the Purchaser, $.01 par value 
per share.

     "Securities Act" means the Securities Act of 1933, as amended.

     "Securities Exchange Act" means the Securities Exchange Act of 1934, as 
amended.

     "Security Interest" means any mortgage, pledge, lien, encumbrance, charge, 
or other security interest, other than (a) mechanic's, materialmen's, and 
similar liens, (b) liens for Taxes not yet due and payable, (c) purchase money 
liens and liens securing rental payments under capital lease arrangements, and 
(d) other liens arising in the Ordinary Course of Business and not incurred in 
connection with the borrowing of money.

     "Seller" has the meaning set forth in the preface above.

     "Sellers' Disclosure Letter" has the meaning set forth in Section 3(a) 
below.

     "Service Agreement" means the Service Agreement between the Purchaser and 
the Group to be executed and delivered by the Purchaser and the Group, and 
which will become effective, at the time of Closing.

     "Shares" means all of the issued and outstanding shares of the Common 
Stock, par value $1.00 per share, of the Association.

     "Tax" means any federal, state, local, or foreign income, gross receipts, 
license, payroll, employment, excise, severance, stamp, occupation, premium, 
windfall profits, environmental (including taxes under Code Sec. 59A), customs 
duties, capital stock, franchise, profits, withholding, social security (or 
similar), unemployment, disability, real property, personal property, sales, 
use, transfer, registration, value added, alternative or add-on minimum, 
estimated, or other tax of any kind whatsoever, including any interest, 
penalty, or addition thereto, whether disputed or not.
 
     "Tax Return" means any return, declaration, report, claim for refund, or 
information return or statement relating to Taxes, including any schedule or 
attachment thereto, and including any amendment thereof.

     "Third Party Claim" has the meaning set forth in Section 9(d) below.

     "Warrants" means warrants to purchase 160,000 shares of Response Stock at 
$12.50 per share, issuable to the Sellers at Closing in the form set forth as 
Exhibit 2(b)(ii).

     2.  PURCHASE AND SALE OF SHARES.

     (a)  BASIC TRANSACTION.  On and subject to the terms and conditions of 
this Agreement, the Purchaser agrees to purchase from the Sellers, and the 
Sellers agree to sell to the Purchaser, all of the Shares for the sum of (i) 
the aggregate base price (the "Base Purchase Price") equal to the sum of Ten 
Million Three Hundred Three Thousand Seven Hundred Twenty-Two Dollars 
($10,303,722.00), plus the Net Realizable Value of Receivables, and (ii) the 
deferred price (the "Deferred Purchase Price") equal to Fifty Thousand Dollars 
($50,000.00) per calendar quarter for each quarter, or portion thereof, that 
the Service Agreement remains if effect, up to a maximum of Eight Hundred 
Thousand Dollars ($800,000).  In the event of termination of the Service 
Agreement on any day which is not the last day of a calendar quarter, then the 
Deferred Purchase Price shall be pro rated through the last day of the calendar 
month of termination as if such termination occurred on that day.  In addition 
to the foregoing, the Purchaser shall issue to each Seller, at such Seller's 
election, either (i) a Warrant to purchase 20,000 shares Response Stock, (ii) 
options to purchase 20,000 shares of Response Stock at a price of $12.50 per 
share, which options shall be issued pursuant to the Purchaser's Non-Qualified 
Stock Option Plan, or (iii) any combination of Warrants and options.  At the 
time of such issuance, any options issued to any Seller pursuant to said plan 
shall be immediately vested and exercisable. 

     (b)  PAYMENT OF PURCHASE PRICE.  The Purchaser shall pay or satisfy the 
Base Purchase Price in the following manner: (i) Five Million Two Hundred 
Thousand ($5,343,750) Dollars in cash to the Sellers, pro rata according to 
their ownership of Shares, at Closing (hereinafter defined), (ii) Five Million 
Nine Hundred Fifty-Nine Thousand Nine Hundred Seventy-Two ($5,959,972) Dollars 
by issuance and delivery of the Long-Term Note to the Sellers; and (iii) 
issuance and delivery of the Warrants and/or option to the Sellers in 
accordance with Section 2(a) above.  The Deferred Purchase Price shall be paid 
to the Sellers, pro rata according to their ownership of Shares, by the 
Purchaser Fifty Thousand Dollars (or such portion thereof as may be computed in 
accordance with Section 2(a) in the event of termination of the Service 
Agreement) in arrears on the last day of each calendar quarter, commencing 
March 31, 1996 (which date is subject to change in the event the Closing occurs 
later than January 2, 1996), with the last such payment being due and payable 
on the earlier of the last day of the quarter during which the Service 
Agreement is terminated or December 31, 1999.  In addition to the foregoing, 
the Purchaser shall pay to the Sellers, pro rata according to their ownership 
of Shares, as additional Purchase Price, on a monthly basis during the period 
after Closing, the amount of Receivables collected by Response in excess of 
$1,200,000.00.  Such obligation shall terminate on the first anniversary of the 
Closing.  In that regard, during such one year period, the Purchaser shall make 
monthly accountings to the Sellers with respect to the collection of 
Receivables, and the Sellers may, at their option and sole expense, assist in 
the collection of any Receivable.

     (c)  THE CLOSING.  The closing of the transactions contemplated by this 
Agreement (the "Closing") shall take place at the offices of Baker, Donelson, 
Bearman & Caldwell, 165 Madison Avenue, 21st Floor, Memphis, Tennessee 38103 
commencing at 9:00 a.m. local time on January 2, 1996, or such other date as 
the Purchaser and the Sellers may mutually determine (the "Closing Date").

     (d)  DELIVERIES AT THE CLOSING.  At the Closing, (i) the Purchaser will 
deliver to the Sellers the various certificates, instruments, and documents 
referred to in Section 8(a) below, (ii) the Sellers will deliver to the 
Purchaser the various certificates, instruments, and documents referred to in 
Section 8(b) below.

     3.  REPRESENTATIONS AND WARRANTIES CONCERNING THE TRANSACTION.

     (a)  REPRESENTATIONS AND WARRANTIES OF THE SELLERS.  The Sellers jointly 
and severally represent and warrant to the Purchaser that the statements 
contained in this Section 3(a) are correct and complete as of the date of this 
Agreement with respect to the Sellers, except as set forth in the disclosure 
letter executed and delivered by the Sellers and the Group contemporaneous with 
this Agreement (the "Sellers' Disclosure Letter"").  The Sellers' Disclosure 
Letter shall be satisfactory to the Purchaser and its counsel and will be 
arranged in paragraphs corresponding to the lettered and numbered paragraphs 
contained in this Section 3(a) and Section 4.

          (i)  AUTHORIZATION OF TRANSACTION.  Each Seller has the requisite 
legal capacity and has full power and authority to execute and deliver this 
Agreement and to perform his obligations hereunder.  This Agreement constitutes 
the valid and legally binding obligation of each Seller, enforceable in 
accordance with its terms and conditions.  Each Seller need not give any notice 
to, make any filing with, or obtain any authorization, consent, or approval of 
any government or governmental agency in order to consummate the transactions 
contemplated by this Agreement.  This Agreement constitutes the valid and 
legally binding obligation of each Seller, enforceable in accordance with its 
terms, subject to applicable bankruptcy, moratorium, insolvency and other laws 
affecting the rights of creditors and general equity principles.

          (ii)  NONCONTRAVENTION.  Neither the execution and the delivery of 
this Agreement, nor the consummation of the transactions contemplated hereby, 
will (A) violate any constitution, statute, regulation, rule, injunction, 
judgment, order, decree, ruling, charge, or other restriction of any 
government, governmental agency, or court to which any Seller is subject or (B) 
conflict with, result in a breach of, constitute a default under, result in the 
acceleration of, create in any party the right to accelerate, terminate, 
modify, or cancel, or require any notice under any agreement, contract, lease, 
license, instrument, or other arrangement to which any Seller is a party or by 
which he is bound or to which any of his assets is subject.

          (iii)  BROKERS' FEES.  The Sellers have no Liability or obligation to 
pay any fees or commissions to any broker, finder, or agent with respect to the 
transactions contemplated by this Agreement for which the Purchaser could 
become liable or obligated.

          (iv)  SHARES.  Each Seller holds of record and owns beneficially all 
of the Shares free and clear of any restrictions on transfer (other than any 
restrictions under the Securities Act and state securities laws), Taxes, 
Security Interests, options, warrants, purchase rights, contracts, commitments, 
equities, claims, and demands.  No Seller is a party to any option, warrant, 
purchase right, or other contract or commitment that could require the Seller 
to sell, transfer, or otherwise dispose of any capital stock of the Association 
(other than this Agreement).  No Seller is a party to any voting trust, proxy, 
or other agreement or understanding with respect to the voting of any Shares.

          (v)  AGREEMENT AMONG SELLERS.  The Agreement among Sellers has been 
duly executed by each Seller and constitutes the valid and legally binding 
obligation of each Seller, enforceable according to its terms.

     (b)  REPRESENTATIONS AND WARRANTIES OF THE PURCHASER.  The Purchaser 
represents and warrants to each Seller that the statements contained in this 
Section 3(b) are correct and complete as of the date of this Agreement except 
as set forth in the disclosure letter executed and delivered by the Purchaser 
contemporaneous with this Agreement (the "Purchaser's Disclosure Letter"). 

          (i)  ORGANIZATION OF THE PURCHASER.  The Purchaser is a corporation 
duly organized, validly existing, and in good standing under the laws of the 
State of Tennessee. 

          (ii)  AUTHORIZATION OF TRANSACTION.  The Purchaser has full power and 
authority (including full corporate power and authority) to execute and deliver 
this Agreement and to perform its obligations hereunder.  This Agreement 
constitutes the valid and legally binding obligation of the Purchaser, 
enforceable in accordance with its terms, subject to applicable bankruptcy, 
moratorium, insolvency and other laws affecting the rights of creditors and 
general equity principles.  The Purchaser need not give any notice to, make any 
filing with, or obtain any authorization, consent, or approval of any 
government or governmental agency in order to consummate the transactions 
contemplated by this Agreement.

          (iii)  NONCONTRAVENTION.  Neither the execution and the delivery of 
this Agreement, nor the consummation of the transactions contemplated hereby, 
will (A) violate any constitution, statute, regulation, rule, injunction, 
judgment, order, decree, ruling, charge, or other restriction of any 
government, governmental agency, or court to which the Purchaser is subject or 
any provision of its charter or bylaws or (B) conflict with, result in a breach 
of, constitute a default under, result in the acceleration of, create in any 
party the right to accelerate, terminate, modify, or cancel, or require any 
notice under any agreement, contract, lease, license, instrument, or other 
arrangement to which the Purchaser is a party or by which it is bound or to 
which any of its assets is subject.

          (iv)  BROKERS' FEES.  The Purchaser has no Liability or obligation to 
pay any fees or commissions to any broker, finder, or agent with respect to the 
transactions contemplated by this Agreement for which the Seller could become 
liable or obligated.

          (v)  INVESTMENT.  The Purchaser is not acquiring the Shares with a 
view to or for sale in connection with any distribution thereof within the 
meaning of the Securities Act.

     4.  REPRESENTATIONS AND WARRANTIES CONCERNING THE ASSOCIATION.  The 
Sellers and the Group, jointly and severally, represent and warrant to the 
Purchaser that the statements contained in this Section 4 are true, correct and 
complete as of the date of this Agreement and will be correct and complete as 
of the Closing Date (as though made then and as though the Closing Date were 
substituted for the date of this Agreement throughout this Section 4), except 
as set forth in the Sellers' Disclosure Letter.  Nothing in the Sellers' 
Disclosure Letter shall be deemed adequate to disclose an exception to a 
representation or warranty made herein unless the Sellers' Disclosure Letter 
identifies the exception with reasonable particularity and describes the 
relevant facts in reasonable detail.  The Sellers' Disclosure Letter will be 
arranged in paragraphs corresponding to the lettered and numbered paragraphs 
contained in this Section 4.

     (a)  ORGANIZATION, QUALIFICATION, AND CORPORATE POWER.  The Association is 
a corporation duly organized, validly existing, and in good standing under the 
laws of the State of Florida.  The Association is duly authorized to conduct 
business and are in good standing under the laws of each jurisdiction where 
such qualification is required.  The Association has full corporate power and 
authority and all licenses, permits, and authorizations necessary to carry on 
the business in which it is engaged and to own and use its properties.  
Paragraph 4(a) of the Sellers' Disclosure Letter lists the directors and 
officers of the Association. The Sellers have delivered to the Purchaser 
correct and complete copies of the charter and bylaws of the Association (as 
amended to date).  The minute book (containing the records of meetings of the 
stockholders, the board of directors, and any committees of the board of 
directors), the stock certificate book, and the stock record book of the 
Association are correct and complete.  The Association is not in default under 
or in violation of any provision of its charter or bylaws.

     (b)  CAPITALIZATION.  The entire authorized capital stock of the 
Association consists of 5,000 Shares, of which 80 Shares are issued and 
outstanding.  All of the issued and outstanding Shares have been duly 
authorized, are validly issued, fully paid, and nonassessable, and are held of 
record by the Sellers.  There are no outstanding or authorized options, 
warrants, purchase rights, preemptive rights, subscription rights, conversion 
rights, exchange rights, or other contracts or commitments that could require 
the Association to issue, sell, or otherwise cause to become outstanding any of 
its capital stock.  There are no outstanding or authorized stock appreciation, 
phantom stock, profit participation, or similar rights with respect to the 
Association.  There are no voting trusts, proxies, or other agreements or 
understandings with respect to the voting of the capital stock of the 
Association.

     (c)  NONCONTRAVENTION.  Neither the execution and the delivery of this 
Agreement, nor the consummation of the transactions contemplated hereby, will 
(i) violate any constitution, statute, regulation, rule, injunction, judgment, 
order, decree, ruling, charge, or other  restriction of any government, 
governmental agency, or court to which the Association is subject or any 
provision of the charter or bylaws of the Association or (ii) conflict with, 
result in a breach of, constitute a default under, result in the acceleration 
of, create in any party the right to accelerate, terminate, modify, or cancel, 
or require any notice under any agreement, contract, lease, license, 
instrument, or other arrangement to which the Association is a party or by 
which it is bound or to which any of its assets is subject (or result in the 
imposition of any Security Interest upon any of its assets).  The Association 
is not required to give any notice to, make any filing with, or obtain any 
authorization, consent, or approval of any government or governmental agency in 
order for the Parties to consummate the transactions contemplated by this 
Agreement.

     (d)  BROKERS' FEES.  The Association has no Liability or obligation to pay 
any fees or commissions to any broker, finder, or agent with respect to the 
transactions contemplated by this Agreement.

     (e)  TITLE TO ASSETS.  The Association has good and marketable title to, 
or a valid leasehold interest in, all of its properties and assets, free and 
clear of all Security Interests, and has not sold, transferred, exchanged or 
conveyed any of its properties and assets since the date of the Most Recent 
Balance Sheet except for properties and assets disposed of in the Ordinary 
Course of Business since the date of the Most Recent Balance Sheet.

     (f)  FINANCIAL STATEMENTS.  Attached as collective Paragraph 4(f) to the 
Sellers' Disclosure Letter are the following financial statements (collectively 
the "Financial Statements"): (i) unaudited balance sheet and statement of 
income, changes in stockholders' equity, and cash flow as of and for the fiscal 
years ended December 31, 1994 (the "Most Recent Fiscal Year End") for the 
Association; and (ii) unaudited balance sheet and statement of income, changes 
in stockholders' equity, and cash flow (the "Most Recent Financial Statements") 
as of and for the six (6) months ended June 30, 1995 (the "Most Recent Fiscal 
Month End") for the Association.  The Financial Statements (including the notes 
thereto) have been prepared on a consistent basis throughout the periods 
covered thereby, present fairly the financial condition of the Association as 
of such dates and the results of operations of the Association and its 
subsidiaries for such periods on a cash basis method of accounting, are correct 
and complete, and are consistent with the books and records of the Association. 

     (g)  EVENTS SUBSEQUENT TO MOST RECENT FISCAL YEAR END.  Since the Most 
Recent Fiscal Year End, there has not been any material adverse change in the 
business, financial condition, operations, results of operations, or future 
prospects of the Association. Without limiting the generality of the foregoing, 
since that date:

          (i) the Association has not sold, leased, transferred, or assigned 
any of its assets, tangible or intangible, other than for a fair consideration 
in the Ordinary Course of Business;

          (ii) the Association has not entered into any agreement, contract, 
lease, or license (or series of related agreements, contracts, leases, and 
licenses) either involving more than $25,000.00 or outside the Ordinary Course 
of Business;

          (iii) no party (including the Association) has accelerated, 
terminated, modified, or cancelled any agreement, contract, lease, or license 
(or series of related agreements, contracts, leases, and licenses) involving 
more than $25,000.00 to which the Association is a party or by which the 
Association or its properties are bound;

          (iv) the Association has not created, suffered or permitted to attach 
or be imposed any Security Interest upon any of its assets, tangible or 
intangible;

          (v) the Association has not made any capital expenditure (or series 
of related capital expenditures) either involving more than $25,000.00 or 
outside the Ordinary Course of Business;

          (vi) the Association has not made any capital investment in, any loan 
to, or any acquisition of the securities or assets of, any other Person (or 
series of related capital investments, loans, and acquisitions) either 
involving more than $25,000.00 or outside the Ordinary Course of Business;

          (vii) the Association has not issued any note, bond, or other debt 
instrument or security or created, incurred, assumed, or guaranteed any 
indebtedness for borrowed money or capitalized lease obligation; 

          (viii) the Association has not delayed or postponed the payment of 
accounts payable and other Liabilities outside the Ordinary Course of Business;

          (ix) the Association has not cancelled, compromised, waived, or 
released any right or claim (or series of related rights and claims) either 
involving more than $25,000.00 or outside the Ordinary Course of Business;

          (x) the Association has not granted any license or sublicense of any 
rights under or with respect to any Intellectual Property;

          (xi) there has been no change made or authorized in the charter or 
bylaws of the Association; 

          (xii) the Association has not issued, sold, or otherwise disposed of 
any of its capital stock, or granted any options, warrants, or other rights to 
purchase or obtain (including upon conversion, exchange, or exercise) any of 
its capital stock;

          (xiii) the Association has not declared, set aside, or paid any 
dividend or made any distribution with respect to its capital stock (whether in 
cash or in kind) or redeemed, purchased, or otherwise acquired any of its 
capital stock;

          (xiv) the Association has not experienced any damage, destruction, or 
loss (whether or not covered by insurance) to its property;

          (xv) the Association has not made any loan to, or entered into any 
other transaction with, any of its directors, officers, and employees outside 
the Ordinary Course of Business;

          (xvi) the Association has not entered into any employment contract or 
collective bargaining agreement, written or oral, or modified the terms of any 
existing such contract or agreement;

          (xvii) the Association has not granted any increase in the base 
compensation of any of its directors, officers, and employees outside the 
Ordinary Course of Business;

          (xviii) the Association has not adopted, amended, modified, or 
terminated any bonus, profit sharing, incentive, severance, or other plan, 
contract, or commitment for the benefit of any of its directors, officers, and 
employees (or taken any such action with respect to any other Employee Benefit 
Plan);

          (xix) the Association has not made any other change in employment 
terms for any of its directors, officers, and employees outside the Ordinary 
Course of Business;

          (xx) the Association has not made or pledged to make any charitable 
or other capital contribution outside the Ordinary Course of Business;

          (xxi) there has not been any other occurrence, event, incident, 
action, failure to act, or transaction outside the Ordinary Course of Business 
involving the Association; and

          (xxii) the Association has not committed to any of the foregoing.

     (h)  UNDISCLOSED LIABILITIES.  The Association has no Liability (and there 
is no Basis for any present or future action, suit, proceeding, hearing, 
investigation, charge, complaint, claim, or demand against the Association that 
may result in any Liability), except for (i) Liabilities set forth on the face 
of the Most Recent Balance Sheet (rather than in any notes thereto); (ii) 
Liabilities which have arisen after the Most Recent Fiscal Month End in the 
Ordinary Course of Business and (iii) Liabilities described with particularity 
in Paragraph 4(h) of the Sellers' Disclosure Letter (and, with respect to each 
Liability described in items (i) through (iii) immediately above, none of which 
results from, arises out of, relates to, is in the nature of, or was caused by 
any breach of contract, breach of warranty, tort, malpractice, infringement, or 
violation of law).

     (i)  LEGAL COMPLIANCE.  The Association and its respective predecessors 
and Affiliates have complied with all applicable laws (including rules, 
regulations, codes, plans, injunctions, judgments, orders, decrees, rulings, 
and charges thereunder) of federal, state, local, and foreign governments (and 
all agencies thereof), and no action, suit, proceeding, hearing, investigation, 
charge, complaint, claim, demand, or notice has been filed or commenced against 
any of them alleging any failure so to comply.

     (j)  TAX MATTERS.

          (i) The Association has filed all Tax Returns that it was required to 
file.  All such Tax Returns were correct and complete in all respects.  All 
Taxes owed by the Association (whether or not shown on any Tax Return) have 
been paid or accrued in the Financial Statements.  The Association is not the 
beneficiary of any extension of time within which to file any Tax Return.  No 
claim has ever been made by an authority in a jurisdiction where the 
Association does not file Tax Returns that it is or may be subject to taxation 
by that jurisdiction.  There are no Security Interests on any of the assets of 
either the Association that arose in connection with any failure (or alleged 
failure) to pay any Tax.

          (ii) The Association has withheld and paid all Taxes required to have 
been withheld and paid in connection with amounts paid or owing to any 
employee, independent contractor, creditor, stockholder, or other third party.

          (iii) Neither the Sellers nor any director or officer (or employee 
responsible for Tax matters) of the Association expects any authority to assess 
any additional Taxes for any period for which Tax Returns have been filed.  
There is no dispute or claim concerning any Tax Liability of the Association 
either (A) claimed or raised by any authority in writing or (B) as to which the 
Sellers or the directors and officers (and employees responsible for Tax 
matters) of the Association have Knowledge.  Paragraph 4(j) of the Sellers' 
Disclosure Letter lists all federal, state, local, and foreign income Tax 
Returns filed with respect to the Association for taxable periods ended on or 
after December 31, 1992, indicates those Tax Returns that have been audited, 
and indicates those Tax Returns that currently are the subject of audit.  The 
Sellers have delivered to the Purchaser correct and complete copies of all 
examination reports and statements of deficiencies assessed against or agreed 
to by the Association since December 31, 1991.

          (iv) The Association has not waived any statute of limitations in 
respect of Taxes or agreed to any extension of time with respect to a Tax 
assessment or deficiency.

          (v) The Association has not filed a consent under Code Section 341(f) 
concerning collapsible corporations.  The Association has not made any payment, 
is not obligated to make any payment, or is not a party to any agreement that 
under certain circumstances could obligate it to make any payments that will 
not be deductible under Code Section 280G.  The Association has not been a 
United States real property holding corporation within the meaning of Code Sec. 
897(c)(2) during the applicable period specified in Code Section 
897(c)(1)(A)(ii).  The Association has not disclosed on its federal income Tax 
Returns all positions taken therein that could give rise to a substantial 
understatement of federal income Tax within the meaning of Code Section 6662.  
The Association is not a party to any Tax allocation or sharing agreement.  The 
Association (A) has not been a member of an Affiliated Group filing a 
consolidated federal income Tax Return or (B) has no Liability for the Taxes of 
any Person (other than of the Association under Treasury Regulation 1.1502 6 
(or any similar provision of state, local, or foreign law), as a transferee or 
successor, by contract, or otherwise.

          (vi)  Paragraph 4(j) of the Sellers' Disclosure Letter sets forth the 
following information with respect to the Association as of the most recent 
practicable date: (A) the basis of the Association in its assets; and (B) the 
amount of any net operating loss, net capital loss, unused investment or other 
credit, unused foreign tax, or excess charitable contribution.

     (k)  REAL PROPERTY.  The Association does not own any real property and 
has not executed and delivered or otherwise entered into any contract to 
purchase any real property.  Paragraph 4(k) of the Sellers' Disclosure Letter 
lists and describes briefly all real property leased or subleased to the 
Association.  The Sellers have delivered to the Purchaser correct and complete 
copies of the leases and subleases listed in Paragraph 4(k) of the Sellers' 
Disclosure Letter (as amended to date).  With respect to each lease and 
sublease listed in Paragraph 4(k) of the Sellers' Disclosure Letter, except as 
otherwise set forth in such Paragraph 4(k) of the Sellers' Disclosure Letter:

          (i)  the lease or sublease is legal, valid, binding, enforceable, and 
in full force and effect;

          (ii)  the lease or sublease will continue to be legal, valid, 
binding, enforceable, and in full force and effect on identical terms following 
the consummation of the transactions contemplated hereby;

          (iii)  the Association, and, to the best of Sellers' Knowledge, no 
other party to the lease or sublease is in breach or default, and no event has 
occurred which, with notice or lapse of time, would constitute a breach or 
default or permit termination, modification, or acceleration thereunder;

          (iv)  the Association, and, to the best of Sellers' Knowledge, no 
party to the lease or sublease has repudiated any provision thereof;

          (v)  to the best of Sellers' Knowledge, there are no disputes, oral 
agreements, or forbearance programs in effect as to the lease or sublease;

          (vi)  with respect to each sublease, the representations and 
warranties set forth in subsections (i) through (v) above are true and correct 
with respect to the underlying lease;

          (vii)  the Association has not assigned, transferred, conveyed, 
mortgaged, deeded in trust, or encumbered any interest in the leasehold or 
subleasehold;

          (viii)  all facilities leased or subleased thereunder have received 
all approvals of governmental authorities (including licenses and permits) 
required in connection with the operation thereof and have been operated and 
maintained in accordance with applicable laws, rules, and regulations;

          (ix)  all facilities leased or subleased thereunder are supplied with 
utilities and other services necessary for the operation of said facilities; 
and

          (x)  to the best of Sellers' Knowledge, the owner of the facility 
leased or subleased has good and marketable title to the parcel of real 
property, free and clear of any Security Interest, easement, covenant, or other 
restriction, except for installments of special easements not yet delinquent 
and recorded easements, covenants, and other restrictions which do not impair 
the current use, occupancy, or value, or the marketability of title, of the 
property subject thereto.

     (l)  TANGIBLE ASSETS.  The Association owns or leases all buildings, 
machinery, equipment, and other tangible assets necessary for the conduct of 
its business as presently conducted.  

     (m)  INVENTORY.  The inventory of the Association consists of medical 
supplies, all of which is merchantable and fit for the purpose for which it was 
procured or manufactured, and none of which is slow moving, obsolete, damaged, 
or defective, subject only to the reserve for inventory writedown set forth on 
the face of the Most Recent Balance Sheet (rather than in any notes thereto) as 
adjusted for the passage of time through the Closing Date in accordance with 
the past custom and practice of the Association.

     (n)  CONTRACTS.  Paragraph 4(n) of the Sellers' Disclosure Letter lists 
the following contracts and other agreements to which the Association is a 
party:

          (i) any agreement (or group of related agreements) for the lease of 
personal property to or from any Person providing for lease payments in excess 
of $25,000.00 per annum;

          (ii) any agreement (or group of related agreements) for the purchase 
or sale of raw materials, commodities, supplies, products, or other personal 
property, or for the furnishing or receipt of services, the performance of 
which will extend over a period of more than one year, result in a loss to the 
Association, or involve consideration in excess of $25,000.00;

          (iii) any agreement concerning a partnership or joint venture;

          (iv) any agreement (or group of related agreements) under which the 
Association has created, incurred, assumed, or guaranteed any indebtedness for 
borrowed money, or any capitalized lease obligation, in excess of $25,000.00 or 
under which it has imposed a Security Interest on any of its assets, tangible 
or intangible;

          (v) any agreement concerning confidentiality or noncompetition;

          (vi) any agreement with either the Sellers or their Affiliates (other 
than the Association);

          (vii) any profit sharing, stock option, stock purchase, stock 
appreciation, deferred compensation, severance, or other plan or arrangement 
for the benefit of its current or former directors, officers, and employees;

          (viii) any collective bargaining agreement;

          (ix) any agreement for the employment of any individual on a full-
time, part-time, consulting, or other basis providing annual compensation in 
excess of $25,000.00 or providing severance benefits;

          (x) any agreement under which the Association has advanced or loaned 
any amount to any of its directors, officers,  and employees outside the 
Ordinary Course of Business;

          (xi) any agreement under which the consequences of a default or 
termination could have an adverse effect on the business, financial condition, 
operations, results of operations, or future prospects of the Association; or

          (xii) any other agreement (or group of related agreements) the 
performance of which involves consideration in excess of $25,000.00.

The Sellers has delivered to the Purchaser a correct and complete copy of each 
written agreement listed in Paragraph 4(n) of the Sellers' Disclosure Letter 
(as amended to date) and a written summary setting forth the terms and 
conditions of each oral agreement referred to in Paragraph 4(n) of the Sellers' 
Disclosure Letter.  With respect to each such agreement: (1) the agreement is 
legal, valid, binding, enforceable, and in full force and effect; (2) the 
agreement will continue to be legal, valid, binding, enforceable, and in full 
force and effect on identical terms following the consummation of the 
transactions contemplated hereby; (3) no party is in breach or default, and no 
event has occurred which with notice or lapse of time would constitute a breach 
or default, or permit termination, modification, or acceleration, under the 
agreement; and (4) no party has repudiated any provision of the agreement.

     (o)  NOTES AND ACCOUNTS RECEIVABLE.  All notes and accounts receivable of 
the Association are reflected properly on its books and records, are valid 
receivables subject to no setoffs or counterclaims, are current and 
collectible, and will be collected in accordance with their terms at their 
recorded amounts, subject only to the reserve for bad debts as adjusted for the 
passage of time through the Closing Date in accordance with the past custom and 
practice of the Association.

     (p)  POWERS OF ATTORNEY.  There are no outstanding powers of attorney 
executed on behalf of the Association.

     (q)  INSURANCE.  Paragraph 4(q) of the Sellers' Disclosure Letter sets 
forth the following information with respect to each insurance policy 
(including policies providing property, casualty, liability, medical 
malpractice, and workers' compensation coverage and bond and surety 
arrangements) to which the Association has been a party, a named insured, or 
otherwise the beneficiary of coverage at any time within the past five (5) 
years:

          (i)  the name, address, and telephone number of the agent;

          (ii)  the name of the insurer, the name of the policyholder, and the 
name of each covered insured;

          (iii)  the policy number and the period of coverage;

          (iv)  the scope (including an indication of whether the coverage was 
on a claims made, occurrence, or other basis) and amount (including a 
description of how deductibles and ceilings are calculated and operate) of  
coverage; and

          (v) a description of any retroactive premium adjustments or other 
loss-sharing arrangements.

With respect to each such insurance policy: (A) the policy is legal, valid, 
binding, enforceable, and in full force and effect; (B) the policy will 
continue to be legal, valid, binding, enforceable, and in full force and effect 
on identical terms following the consummation of the transactions contemplated 
hereby; (C) neither the Association nor any other party to the policy is in 
breach or default (including with respect to the payment of premiums or the 
giving of notices), and no event has occurred which, with notice or the lapse 
of time, would constitute such a breach or default, or permit termination, 
modification, or acceleration, under the policy; and (D) no party to the policy 
has repudiated any provision thereof.  The Association has been covered during 
the past five (5) years by insurance in scope and amount customary and 
reasonable for the businesses in which it has engaged during the aforementioned 
period.  Paragraph 4(q) of the Sellers' Disclosure Letter describes any self-
insurance arrangements affecting the Association.

     (r)  LITIGATION.  Paragraph 4(r) of the Sellers' Disclosure Letter sets 
forth each instance in which either the Association (i) is subject to any 
outstanding injunction, judgment, order, decree, ruling, or charge or (ii) is a 
party or is threatened to be made a party to any action, suit, proceeding, 
hearing, or investigation of, in, or before any court or quasi-judicial or 
administrative agency of any federal, state, local, or foreign jurisdiction or 
before any arbitrator.  None of the actions, suits, proceedings, hearings, and 
investigations set forth in Paragraph 4(r) of the Sellers' Disclosure Letter 
could result in any material adverse change in the business, financial 
condition, operations, results of operations, or future prospects of either the 
Association or the Group.  Neither the Sellers nor the directors and officers 
(and employees with responsibility for litigation matters) of the Association 
and the Group has any reason to believe that any such action, suit, proceeding, 
hearing, or investigation may be brought or threatened against the Association 
or the Group. 

     (s)  EMPLOYEES.  To the best of the Sellers' Knowledge, no physician, 
executive, key employee, or group of employees has any plans to terminate 
employment with the Association or, after the Closing, with the Group.  The 
Association is not a party to or bound by any collective bargaining agreement, 
nor has it experienced any strikes, grievances filed pursuant to any work rules 
of any organized labor organization, claims of unfair labor practices, or other 
collective bargaining disputes.  To the best of the Sellers' Knowledge, the 
Association has not committed any unfair labor practice.  To the best of the 
Sellers' Knowledge, no organizational effort is presently being made or 
threatened by or on behalf of any labor union with respect to employees of the 
Association.

     (t)  EMPLOYEE BENEFITS.

          (i) Paragraph 4(t) of the Sellers' Disclosure Letter lists each 
Employee Benefit Plan that the Association maintains or to which the 
Association contributes.

               (A) Each such Employee Benefit Plan (and each related trust, 
insurance contract, or fund) complies in form and in operation in all respects 
with the applicable requirements of ERISA, the Code, and other applicable laws.

               (B) All required reports and descriptions (including Form 5500 
Annual Reports, Summary Annual Reports, PBGC-1's, and Summary Plan 
Descriptions) have been filed or distributed appropriately with respect to each 
such Employee Benefit Plan.  The requirements of Part 6 of Subtitle B of Title 
I of ERISA and of Code Sec. 4980B have been met with respect to each such 
Employee Benefit Plan which is an Employee Welfare Benefit Plan.

               (C) All contributions (including all employer contributions and 
employee salary reduction contributions) which are due have been paid to each 
such Employee Benefit Plan which is an Employee Pension Benefit Plan and all 
contributions for any period ending on or before the Closing Date which are not 
yet due have been paid to each such Employee Pension Benefit Plan or accrued in 
accordance with the past custom and practice of the Association.  All premiums 
or other payments for all periods ending on or before the Closing Date have 
been paid with respect to each such Employee Benefit Plan which is an Employee 
Welfare Benefit Plan.

               (D) Each such Employee Benefit Plan which is an Employee Pension 
Benefit Plan meets the requirements of a "qualified plan" under Code Sec. 
401(a) and has received, within the last two years, a favorable determination 
letter from the Internal Revenue Service.

               (E) The market value of assets under each such Employee Benefit 
Plan which is an Employee  Pension Benefit Plan (other than any Multiemployer 
Plan) equals or exceeds the present value of all vested and nonvested 
Liabilities thereunder determined in accordance with PBGC methods, factors, and 
assumptions applicable to an Employee Pension Benefit Plan terminating on the 
date for determination.

               (F) The Sellers have delivered to the Purchaser correct and 
complete copies of the plan documents and summary plan descriptions, the most 
recent determination letter received from the Internal Revenue Service, the 
most recent Form 5500 Annual Report, and all related trust agreements, 
insurance contracts, and other funding agreements which implement each such 
Employee Benefit Plan.

          (ii) With respect to each Employee Benefit Plan that the Association 
maintains or ever has maintained or to which it contributes, ever has 
contributed, or ever has been required to contribute:

               (A)  No such Employee Benefit Plan which is in Employee Pension 
Benefit Plan (other than any Multiemployer Plan) has been completely or 
partially terminated or been the subject of a Reportable Event as to which 
notices would be required to be filed with the PBGC. No proceeding by the PBGC 
to terminate any such Employee Pension Benefit Plan (other than any 
Multiemployer Plan) has been instituted or threatened.

               (B)  There have been no Prohibited Transactions with respect to 
any such Employee Benefit Plan.  No Fiduciary has any Liability for breach of 
fiduciary duty or any other failure to act or comply in connection with the 
administration or investment of the assets of any such Employee Benefit Plan.  
No action, suit, proceeding, hearing, or investigation with respect to the 
administration or the investment of the assets of any such Employee Benefit 
Plan (other than routine claims for benefits) is pending or threatened.  
Neither the Sellers nor the directors and officers (and employees with 
responsibility for employee benefits matters) of the Association has any 
Knowledge of any Basis for any such action, suit, proceeding, hearing, or 
investigation.

               (C)  The Association has not incurred, and neither the Sellers 
nor the directors and officers (and employees with responsibility for employee 
benefits matters) of the Association has any reason to expect that the 
Association will incur, any Liability to the PBGC (other than PBGC premium 
payments) or otherwise under Title IV of ERISA (including any withdrawal 
Liability) or under the Code with respect to any such Employee Benefit Plan 
which is an Employee Pension Benefit Plan.

          (iii) The Association does not contribute to, has never contributed 
to, and has not been required to contribute to any Multiemployer Plan or has 
any Liability (including withdrawal Liability) under any Multiemployer Plan.

          (iv) The Association does not maintain, has never maintained, has 
never contributed, and has not been required to contribute to any Employee 
Welfare Benefit Plan providing medical, health, or life insurance or other 
welfare-type benefits for current or future retired or terminated employees, 
their spouses, or their dependents (other than in accordance with Code Sec. 
4980B).

     (u)  GUARANTIES.  The Association is not a guarantor or is not otherwise 
liable for any Liability or obligation (including indebtedness) of any other 
Person.

     (v)  ENVIRONMENT, HEALTH, AND SAFETY.

          (i)  Each of the Sellers, the Association and their respective 
Affiliates has complied with all Environmental, Health, and Safety Laws, and no 
action, suit, proceeding, hearing, investigation, charge, complaint, claim, 
demand, or notice has been filed or commenced against any of them alleging any 
failure so to comply.  Without limiting the generality of the preceding 
sentence, each of the Sellers, the Association and their respective Affiliates 
has obtained and been in compliance with all of the terms and conditions of all 
permits, licenses, and other authorizations which are required under, and has 
complied with all other limitations, restrictions, conditions, standards, 
prohibitions, requirements, obligations, schedules, and timetables which are 
contained in, all Environmental, Health, and Safety Laws.

          (ii)  The Association has no Liability (and none of the Sellers, the 
Association and their respective Affiliates has handled or disposed of any 
substance, arranged for the disposal of any substance, exposed any employee or 
other individual to any substance or condition, or owned or operated any 
property or facility in any manner that could form the Basis for any present or 
future action, suit, proceeding, hearing, investigation, charge, complaint, 
claim, or demand against the Association giving rise to any Liability) for 
damage to any site, location, or body of water (surface or subsurface), for any 
illness of or personal injury to any employee or other individual, or for any 
reason under any Environmental, Health, and Safety Law.

          (iii)  All properties and equipment used in the business of the 
Sellers, the Association and their respective Affiliates have been free of 
asbestos, PCB's, methylene chloride, trichloroethylene, 1,2-trans-
dichloroethylene, dioxins, dibenzofurans, and Extremely Hazardous Substances.

     (w)  HEALTHCARE COMPLIANCE.  Neither the Association nor any physician 
associated with or employed by the Association has received payment or any 
remuneration whatsoever to induce or encourage the referral of patients or the 
purchase of goods and/or services as prohibited under 42 U.S.C. 1320a 7b(b), 
or otherwise perpetrated any Medicare or Medicaid fraud or abuse nor has any 
fraud or abuse been alleged within the last five (5) years by any government 
agency.  The Association and/or each physician employed thereby is 
participating in or otherwise authorized to receive reimbursement from or is a 
party to Medicare, Medicaid, and other third party payor programs, and, after 
the execution and delivery hereof and of the Service Agreement, the foregoing 
representation shall be true with respect to the Group and all physicians 
employed thereby.  All necessary certifications and contracts required for 
participation in such programs are in full force and effect and have not been 
amended or otherwise modified, rescinded, revoked or assigned and, to the best 
of the Sellers' Knowledge, no condition exists or event has occurred which in 
itself or with the giving of notice or the lapse of time or both would result 
in the suspension, revocation, impairment, forfeiture or non-renewal of any 
such third party payor program.  The Association is and, after the execution 
and delivery hereof and of the Service Agreement, the Group will be, in full 
compliance with the requirements of all such third party payor programs 
applicable thereto.

     (x)  FRAUD AND ABUSE.  The Association and persons and entities providing 
professional services for the Association have not engaged in any activities 
which are prohibited under 42 U.S.C. 1320a 7b, or the regulations promulgated 
thereunder pursuant to such statutes, or related state or local statutes or 
regulations, or which are prohibited by rules of professional conduct, 
including but not limited to the following:  

          (i) knowingly and willfully making or causing to be made a false 
statement or representation of a material fact in any application for any 
benefit or payment; 

          (ii) knowingly and willfully making or causing to be made any false 
statement or representation of a material fact for use in determining rights to 
any benefit or payment; 

          (iii) failing to disclose knowledge by a claimant of the occurrence 
of any event affecting the initial or continued right to any benefit or payment 
on its own behalf or on behalf of another, with intent to fraudulently secure 
such benefit or payment; and 

          (iv) knowingly and willfully soliciting or receiving any remuneration 
(including any kickback, bribe, or rebate), directly or indirectly, overtly or 
covertly, in cash or in kind or offering to pay or receive such remuneration 
(A) in return for referring an individual to a person for the furnishing or 
arranging for the furnishing or any item or service for which payment may be 
made in whole or in part by Medicare or Medicaid, or (B) in return for 
purchasing, leasing, or ordering or arranging for or recommending purchasing, 
leasing, or ordering any good, facility, service or item for which payment may 
be made in whole or in part by Medicare or Medicaid.

     (y)  FACILITY COMPLIANCE.  The Association is duly licensed, and the 
Association and its clinics, offices and facilities are lawfully operated in 
accordance with the requirements of all applicable law and has all necessary 
authorizations for their use and operation, all of which are in full force and 
effect.  There are no outstanding notices of deficiencies relating to the 
Association or any physician employed thereby issued by any governmental 
authority or third party payor requiring conformity or compliance with any 
applicable law or condition for participation of such governmental authority or 
third party payor, and after reasonable and independent inquiry and due 
diligence and investigation, the Association has no Knowledge or reason to 
believe that such necessary authorizations may be revoked or not renewed in the 
ordinary course.

     (z)  RATES AND REIMBURSEMENT POLICIES.  The jurisdiction in which the 
Association is located does not currently impose any restrictions or 
limitations on rates which may be charged to private pay patients receiving 
services provided by the Association.  The Association has no rate appeal 
currently pending before any governmental authority or any administrator of any 
third party payor program.  The Association has no Knowledge of any applicable 
law, which has been enacted, promulgated or issued within the eighteen (18) 
months preceding the date of this Agreement or any such legal requirement 
proposed or currently pending in the jurisdiction in which the Association is 
located which could have a material adverse effect on the Association or may 
result in the imposition of additional Medicaid, Medicare, charity, free care, 
welfare, or other discounted or government assisted patients at the Association 
or require the Association to obtain any necessary authorization which the 
Association does not currently possess.

     (aa)  DISCLOSURE.  The representations and warranties contained in this 
Section 4 and in the Sellers' Disclosure Letter do not contain any untrue or 
misleading statement of a fact. 

     5.  PRE-CLOSING COVENANTS.  The Parties agree as follows with respect to 
the period between the execution of this Agreement and the Closing.

     (a)  GENERAL.  Each of the Parties will use his or its best efforts to 
take all action and to do all things necessary in order to consummate and make 
effective the transactions contemplated by this Agreement (including 
satisfaction of the closing conditions set forth in Section 7 below).

     (b)  NOTICES AND CONSENTS.  The Sellers will cause the Association to give 
any notices to third parties, and will cause the Association to use its best 
efforts to obtain any third-party consents, that may be required by law or the 
terms of any contract to which the Sellers may be subject or that the Purchaser 
may request in connection with the transaction contemplated by this Agreement.  
Each of the Parties will (and the Sellers will cause the Association to) give 
any notices to, make any filings with, and use its best efforts to obtain any 
authorizations, consents, and approvals of governments and governmental 
agencies required to consummate the transaction contemplated by this Agreement.

     (c)  OPERATION OF BUSINESS.  The Sellers will not cause or permit the 
Association or the Group to engage in any practice, take any action, or enter 
into any transaction outside the Ordinary Course of Business.  Without limiting 
the generality of the foregoing, the Sellers will not cause or permit the 
Association to (i) declare, set aside, or pay any dividend or make any 
distribution with respect to its capital stock or redeem, purchase, or 
otherwise acquire any of its capital stock or (ii) otherwise engage in any 
practice, take any action, or enter into any transaction of the sort described 
in Section 4(g) above.

     (d)  PRESERVATION OF BUSINESS.  The Sellers will cause the Association to 
keep its business and properties substantially intact, including its present 
operations, physical facilities, working conditions, and relationships with 
lessors, licensors, suppliers, patients, and employees.

     (e)  FULL ACCESS.  The Sellers will permit, and the Sellers will cause the 
Association to permit, representatives of the Purchaser to have full access at 
all reasonable  times, and in a manner so as not to interfere with the normal 
business operations of the Association, to all premises, properties, personnel, 
books, records (including Tax records), contracts, and documents of or 
pertaining to the Association. 

     (f)  NOTICE OF DEVELOPMENTS.  The Sellers will give prompt written notice 
to the Purchaser of any material adverse development of which any of them 
learns which would constitute or otherwise cause a breach of any of the 
representations and warranties in Section 4 above.  Each Party will give prompt 
written notice to the others of any material adverse development causing a 
breach of any of his or its own representations and warranties in Section 3 
above.  No disclosure by any Party pursuant to this Section 5(f), however, 
shall be deemed to amend or supplement the Sellers' Disclosure Letter or to 
prevent or cure any misrepresentation, breach of warranty, or breach of 
covenant.

     (g)  EXCLUSIVITY.  For so long as this Stock Purchase Agreement shall 
remain in effect, the Sellers will not (and the Sellers will not cause or 
permit the Association to) (i) solicit, initiate, or encourage the submission 
of any proposal or offer from any Person relating to the acquisition of any 
capital stock or other voting securities, or any substantial portion of the 
assets of, the Association (including any acquisition structured as a merger, 
consolidation, or share exchange) or (ii) participate in any discussions or 
negotiations regarding, furnish any information with respect to, assist or 
participate in, or facilitate in any other manner any effort or attempt by any 
Person to do or seek any of the foregoing.  The Sellers will not vote their 
Shares in favor of any such acquisition structured as a merger, consolidation, 
or share exchange.  The Sellers will notify the Purchaser immediately if any 
Person makes any proposal, offer, inquiry, or contact with respect to any of 
the foregoing.

     (h)  RELEASE FROM PERSONAL GUARANTIES.  The Purchaser shall use its best 
efforts to obtain the release of each Seller from any personal guarantee of any 
obligation of the Association.  Failure of the Purchaser to obtain any such 
release shall not be a breach of this Agreement or otherwise, without the 
existence of a separate breach hereof, excuse any Seller from performance 
hereunder.  In that regard, the Purchaser hereby agrees to indemnify and hold 
each Seller harmless from and against any claim made by such Seller in respect 
of any such personal guarantee.

     6.  POST-CLOSING COVENANTS.  The Parties agree as follows with respect to 
the period following the Closing.

     (a)  GENERAL.  In case at any time after the Closing any further action is 
necessary to carry out the purposes of this Agreement, each of the Parties will 
take such further action (including the execution and delivery of such further 
instruments and documents) as any other Party may reasonably request, all at 
the sole cost and expense of the requesting Party (unless the requesting Party 
is entitled to indemnification therefor under Section 9 below).  The Sellers 
acknowledge and agree that from and after the Closing the Purchaser will be 
entitled to possession of all documents, books, records (including Tax 
records), agreements, and financial data of any sort relating to the 
Association.

     (b)  LITIGATION SUPPORT.  In the event and for so long as any Party 
actively is contesting or defending against any action, suit, proceeding, 
hearing, investigation, charge, complaint, claim, or demand in connection with 
(i) any transaction contemplated under this Agreement or (ii) any fact, 
situation, circumstance, status, condition, activity, practice, plan, 
occurrence, event, incident, action, failure to act, or transaction on or prior 
to the Closing Date involving the Association or any Seller, each of the other 
Parties will cooperate with him or it and his or its counsel in the contest or 
defense, make available their personnel, and provide such testimony and access 
to their books and records as shall be necessary in connection with the contest 
or defense, all at the sole cost and expense of the contesting or defending 
Party (unless the contesting or defending Party is entitled to indemnification 
therefor under Section 9 below).

     (c)  TRANSITION.  The Sellers will not take any action that is designed or 
intended to have the effect of discouraging any lessor, licensor, customer, 
supplier, or other business associate of the Association from maintaining the 
same business relationships with the Association or the Group after the Closing 
as it maintained with the Association prior to the Closing.  The Sellers will 
refer all inquiries relating to the businesses of the Association to the 
Purchaser from and after the Closing.

     (d)  NAME CHANGE.  At the time of Closing, the Purchaser shall cause the 
name of the Association to be changed to something distinguishable, within the 
meaning of the corporation statutes of the state of Florida, from the name of 
the Association and shall execute, deliver and/or cause to be filed such 
documents or instruments that may be necessary to permit the Group to change 
its name to and to do business under the name "Oncology Hematology Group of 
South Florida, P.A."

     (e)  MEDICAL DIRECTOR ARRANGEMENT.  From and after Closing, the Parties 
will continue to negotiate in good faith and establish consistent with past 
practice all fees related to the performance by some or all of the Sellers of 
services as medical directors of the Purchaser's IMPACT Center in Miami, 
Florida.

     7.  CONDITIONS PRECEDENT TO OBLIGATION TO CLOSE.

     (a)  CONDITIONS TO OBLIGATION OF THE PURCHASER.  The obligation of the 
Purchaser to consummate the transactions to be performed by it in connection 
with the Closing is subject to satisfaction of the following conditions:

          (i) the representations and warranties set forth in Section 3(a) and 
Section 4 above shall be true and correct in all material respects at and as of 
the Closing Date;

          (ii) the Sellers shall have performed and complied with all of its 
covenants hereunder in all material respects through the Closing;

          (iii) the Sellers shall have caused the Association to procure all of 
the third party consents specified in Section 5(b) above;

          (iv) no action, suit, or proceeding shall be pending or threatened 
before any court or quasi-judicial or administrative agency of any federal, 
state, local, or foreign jurisdiction or before any arbitrator wherein an 
unfavorable injunction, judgment, order, decree, ruling, or charge would (A) 
prevent consummation of any of the transactions contemplated by this Agreement, 
(B) cause any of the transactions contemplated by this Agreement to be 
rescinded following consummation, (C) affect adversely the right of the 
Purchaser to own the Shares and to control the Association, or (D) affect 
adversely the right of the Association to own its assets and to operate its 
businesses (and no such injunction, judgment, order, decree, ruling, or charge 
shall be in effect);

          (v) the Sellers and the Group shall have delivered to the Purchaser a 
certificate to the effect that each of the conditions specified above in 
Section 7(a)(i) (iv) is satisfied in all respects;

          (vi) the Purchaser shall have received the resignations, effective as 
of the Closing, of each director and officer of the Association other than 
those whom the Purchaser shall have specified in writing at least five business 
days prior to the Closing;

          (vii) the Purchaser shall have received from Cohen, Chase, Hoffman & 
Trautman, P.A., counsel to the Sellers and the Association, an opinion as to 
matters customarily addressed in opinions of counsel in transactions such as 
that described herein, which opinion shall be in form and substance reasonably 
acceptable to the Purchaser and its counsel;

          (viii) the Group shall have executed and delivered the Service 
Agreement to the Purchaser;

          (ix)  the President of the Association shall have executed and 
delivered to Baker, Donelson, Bearman & Caldwell, a professional corporation, 
and any state healthcare counsel engaged to render the opinion described in 
subparagraph (x) below, the Certificate of Fact in substantially the form set 
forth as Exhibit 7(a)(ix) hereto

          (x)  the Purchaser shall have received an opinion from Florida 
counsel reasonably satisfactory to the Purchaser that the Service Agreement is 
the legal, valid and binding obligation of the Group, enforceable according to 
its terms (subject to standard bankruptcy, insolvency and principles of equity 
exceptions) and that the performance of the Service Agreement by the Purchaser 
and the Group will not violate any statute, regulation, official 
interpretation, order, decree or other law of the state of Florida;

          (xi)  the Purchaser shall have received an opinion from Baker, 
Donelson, Bearman & Caldwell that the performance of the Service Agreement by 
the Purchaser and the Group will not violate any statute, regulation, official 
interpretation, order, decree or other law of the United States of America;

           (xii)  each Seller shall have executed an employment contract with 
the Group in substantially the form required by the Service Agreement; and

          (xiii)  all actions to be taken by the Sellers in connection with 
consummation of the transactions contemplated hereby and all certificates, 
opinion, instruments, and other documents required to effect the transactions 
contemplated hereby will be satisfactory in form and substance to the 
Purchaser.

The Purchaser may waive any condition specified in this Section 7(a) if it 
executes a writing so stating at or prior to the Closing.

     (b)  CONDITIONS TO OBLIGATION OF THE SELLERS.  The obligation of the 
Sellers to consummate the transactions to be performed by them in connection 
with the Closing is subject to satisfaction of the following conditions:

          (i) the representations and warranties set forth in Section 3(b) 
above shall be true and correct in all material respects at and as of the 
Closing Date;

          (ii) the Purchaser shall have performed and complied with all of its 
covenants hereunder in all material respects through the Closing;

          (iii) no action, suit, or proceeding shall be pending or threatened 
before any court or quasi-judicial or administrative agency of any federal, 
state, local, or foreign jurisdiction or before any arbitrator wherein an 
unfavorable injunction, judgment, order, decree, ruling, or charge would (A) 
prevent consummation of any of the transactions contemplated by this Agreement 
or (B) cause any of the transactions contemplated by this Agreement to be 
rescinded following consummation (and no such injunction, judgment, order, 
decree, ruling, or charge shall be in effect);

          (iv) the Purchaser shall have delivered to the Sellers a certificate 
to the effect that each of the conditions specified above in Section 7(b)(i)-
(iii) is satisfied in all respects;

          (v) all actions to be taken by the Purchaser in connection with 
consummation of the transactions contemplated hereby and all certificates, 
instruments, and other documents required to effect the transactions 
contemplated hereby will be reasonably satisfactory in form and substance to 
the Sellers.

          (vi)  the Sellers shall have received an opinion from Baker, 
Donelson, Bearman & Caldwell, in form and substance satisfactory to the Sellers 
and their counsel with respect to the enforceability of the Long-Term Note and 
the legality of the rate of interest thereupon.

          (vii)  the Sellers shall have received an opinion from Florida 
counsel reasonably satisfactory to the Sellers that the Service Agreement is 
the legal, valid and binding obligation of the Purchaser, enforceable according 
to its terms (subject to standard bankruptcy, insolvency and principles of 
equity exceptions) and that the performance of the Service Agreement by the 
Purchaser and the Group will not violate any statute, regulation, official 
interpretation, order, decree or other law of the state of Florida.

          (viii)  the Sellers shall have received an opinion from Baker, 
Donelson, Bearman & Caldwell that the performance of the Service Agreement by 
the Purchaser and the Group will not violate any statute, regulation, official 
interpretation, order, decree or other law of the United States of America;

The Sellers may waive any condition specified in this Section 7(b) if they 
execute a writing so stating at or prior to the Closing.

     8.  DELIVERIES AT CLOSING.

     (a)  DOCUMENTS TO BE DELIVERED BY THE PURCHASER.  At the Closing, the 
Purchaser shall deliver the following instruments and documents to the Sellers 
or other appropriate party:

          (i)  the amount described in Section 2(b)(i) above;

          (ii)  the Long-Term Note, payable to the order of the Sellers;

          (iii) the Warrants;

          (iv)  the certificate described in Section 7(b)(iv) above;

          (v)  the opinions of counsel, in a form reasonably satisfactory to 
the Sellers' counsel, required pursuant to Sections 7(b)(vi) through (viii) 
above; and

          (vi)  such other documents as the Sellers may reasonably request to 
affect the transactions contemplated by this Agreement.

     (b)  DOCUMENTS TO BE DELIVERED BY THE SELLER.  At the Closing, the Sellers 
shall deliver the following instruments and documents to the Purchaser:

          (i)  stock certificates representing all of the Shares, endorsed in 
blank or accompanied by duly executed assignment documents;

          (ii)  a certificate of existence from the Florida Secretary of State 
evidencing the existence and good standing of the Association, dated not more 
than five (5) days prior to the Closing Date;

          (iii)  all consents necessary regarding the transaction contemplated 
by this Agreement;

          (iv)  the opinion of counsel to the Sellers, in a form reasonably 
satisfactory to the Purchaser's counsel, required by Section 7(a)(vii) above; 

          (v)  the opinion, in a form reasonably acceptable to the Purchaser's 
counsel, required by Section 7(a)(ix) above;

          (vi)  the Certificate described in Section 7(a)(v) above;

          (vii)  the Service Agreement, duly executed by the Group; and

          (viii)  such other documents as the Purchaser may reasonably request 
to affect the transactions contemplated by this Agreement.
 
     9.  REMEDIES FOR BREACHES OF THIS AGREEMENT.

     (a)  SURVIVAL OF REPRESENTATIONS AND WARRANTIES.  All of the 
representations and warranties of the Parties contained in this Agreement shall 
survive the Closing hereunder (even if the damaged Party knew or had reason to 
know of any misrepresentation or breach of warranty at the time of Closing) and 
continue in full force and effect forever thereafter (subject to any applicable 
statutes of limitations).

     (b)  INDEMNIFICATION PROVISIONS FOR BENEFIT OF THE PURCHASER .  In the 
event any of the Sellers breaches (or in the event any third party alleges 
facts that, if true, would mean the Seller has breached), in a manner which has 
a material adverse effect on the Purchaser, any of such Seller's 
representations, warranties, and covenants contained herein and, provided that 
the Purchaser makes a written claim for indemnification against the Seller 
pursuant to Section 9(c)(i) below, then the Sellers and the Group, jointly and 
severally, agree to indemnify the Purchaser from and against the entirety of 
any Adverse Consequences the Purchaser may suffer through and after the date of 
the claim for indemnification (including any Adverse Consequences the Purchaser 
may suffer after the end of any applicable survival period) resulting from, 
arising out of, relating to, in the nature of, or caused by the breach (or the 
alleged breach). or otherwise.

     (c)  MATTERS INVOLVING THIRD PARTIES.

          (i) If any third party shall notify the Purchaser with respect to any 
matter (a "Third Party Claim") which may give rise to a claim for 
indemnification under this Section 9, then the Purchaser shall promptly notify 
the Sellers thereof in writing; provided, however, that no delay on the part of 
the Purchaser in notifying the Sellers shall relieve the indemnitor from any 
obligation hereunder unless (and then solely to the extent) the indemnitor 
thereby are prejudiced.

          (ii) The Sellers and the Group will have the right to defend the 
Purchaser against the Third Party Claim with counsel of its choice satisfactory 
to the Purchaser so long as (A) they notify the Purchaser in writing within 15 
days after the Purchaser has given notice of the Third Party Claim that the 
Sellers will indemnify the Purchaser from and against the entirety of any 
Adverse Consequences the Purchaser may suffer resulting from, arising out of, 
relating to, in the nature of, or caused by the Third Party Claim, (B) the 
Sellers and the Group provides the Purchaser with evidence acceptable to the 
Purchaser that the Sellers and the Group will have the financial resources to 
defend against the Third Party Claim and fulfill his indemnification 
obligations hereunder, (C) the Third Party Claim involves only money damages 
and does not seek an injunction or other equitable relief, (D) settlement of, 
or an adverse judgment with respect to, the Third Party Claim is not, in the 
good faith judgment of the Purchaser, likely to establish a precedential custom 
or practice adverse to the continuing business interests of the Purchaser, and 
(E) the Sellers and the Group conduct the defense of the Third Party Claim 
actively and diligently.

          (iii) So long as the Sellers and the Group are conducting the defense 
of the Third Party Claim in accordance with Section 9(c)(ii) above, (A) the 
Purchaser may retain separate co-counsel at its sole cost and expense and 
participate in the defense of the Third Party Claim, (B) the Purchaser will not 
consent to the entry of any judgment or enter into any settlement with respect 
to the Third Party Claim without the prior written consent of the Sellers and 
the Group (not to be withheld unreasonably), and (C) the Sellers and the Group 
will not consent to the entry of any judgment or enter into any settlement with 
respect to the Third Party Claim without the prior written consent of the 
Purchaser.

          (iv) In the event any of the conditions in Section 9(c)(ii) above is 
or becomes unsatisfied, however, (A) the Purchaser may defend against, and 
consent to the entry of any judgment or enter into any settlement with respect 
to, the Third Party Claim in any manner it may deem appropriate (and the 
Purchaser need not consult with, or obtain any consent from, the Seller in 
connection  therewith), (B) the Sellers and the Group will reimburse the 
Purchaser promptly and periodically for the costs of defending against the 
Third Party Claim (including attorneys' fees and expenses), and (C) the Sellers 
and the Group will remain responsible for any Adverse Consequences the 
Purchaser may suffer resulting from, arising out of, relating to, in the nature 
of, or caused by the Third Party Claim to the fullest extent provided in this 
Section 9.

     (d)  DETERMINATION OF ADVERSE CONSEQUENCES.  The Parties shall take into 
account the time cost of money (using the Applicable Rate as the discount rate) 
in determining Adverse Consequences for purposes of this Section 9.  All 
indemnification payments under this Section 9 shall be deemed adjustments to 
the Purchase Price.

     (e)  RECOUPMENT UNDER THE LONG-TERM NOTE.  In the event that the Purchaser 
shall suffer Adverse Consequences for which indemnification pursuant to the 
foregoing provisions shall be payable by the Sellers and the Sellers shall not 
make any such indemnification payment within sixty (60) days after such 
indemnity amount shall become payable, the Purchaser shall have the option of 
recouping all or any part of any Adverse Consequences it may suffer by 
notifying the Sellers that the Purchaser is offsetting the amount of such 
Adverse Consequences against the principal amount outstanding under the Long-
Term Note.  An offset pursuant to this subsection shall affect the timing and 
amount of payments required under the Long-Term Note in the same manner as if 
the Purchaser had made a permitted prepayment (without premium or penalty) 
thereunder.

     (f)  OTHER INDEMNIFICATION PROVISIONS.  The foregoing indemnification 
provisions are in addition to, and not in derogation of, any statutory, 
equitable, or common law remedy any Party may have for breach of 
representation, warranty, or covenant.  The Sellers hereby agree that they will 
not make any claim for indemnification against the Association by reason of the 
fact that they were directors, officers, employees, or agents of the 
Association or were serving at the request thereof as a partner, trustee, 
director, officer, employee, or agent of another entity (whether such claim is 
for judgments, damages, penalties, fines, costs, amounts paid in settlement, 
losses, expenses, or otherwise and whether such claim is pursuant to any 
statute, charter document, bylaw, agreement, or otherwise) with respect to any 
action, suit, proceeding, complaint, claim, or demand brought by the Purchaser 
against the Sellers (whether such action, suit, proceeding, complaint, claim, 
or demand is pursuant to this Agreement, applicable law, or otherwise).

     10.  TERMINATION.

     (a)  TERMINATION OF AGREEMENT.  Certain of the Parties may terminate this 
Agreement as provided below:

          (i) the Purchaser and the Sellers may terminate this Agreement by 
mutual written consent at any time prior to the Closing;

          (ii) the Purchaser may terminate this Agreement by giving written 
notice to the Sellers at any time prior to the Closing in the event any of the 
Sellers has breached or failed to satisfy in any material respect any 
representation, warranty, covenant or condition contained in this Agreement, 
the Purchaser has notified the Seller of the breach or failure, and the breach 
or failure has continued without cure for a period of 10 days after the notice 
of breach or failure;

          (iii) the Sellers may terminate this Agreement by giving written 
notice to the Purchaser at any time prior to the Closing in the event the 
Purchaser has breached or failed to satisfy in any material respect any 
representation, warranty, covenant or condition contained in this Agreement, 
any of the Sellers has notified the Purchaser of the breach or failure, and the 
breach or failure has continued without cure for a period of 10 days after the 
notice of breach or failure; and

          (iv)  if the Closing shall not have occurred on or before February 
29, 1996 (unless the failure to close is primarily attributable to the breach 
of or failure to satisfy any representation, warranty, covenant or condition 
contained in this Agreement by the Party seeking to terminate this Agreement).

     (b)  EFFECT OF TERMINATION.  If any Party terminates this Agreement 
pursuant to Section 10(a) above, all rights and obligations of the Parties 
hereunder shall terminate without any Liability of any Party to any other Party 
(except for any Liability of any Party then in breach).

     11.  MISCELLANEOUS.

     (a)  PRESS RELEASES AND PUBLIC ANNOUNCEMENTS.  No Party shall issue any 
press release or make any public announcement relating to the subject matter of 
this Agreement without the prior written approval of the Purchaser and the 
Seller; provided, however, that any Party may make any public disclosure it 
believes in good faith is required by applicable law or any listing or trading 
agreement concerning its publicly-traded securities (in which case the 
disclosing Party will use its best efforts to advise the other Parties prior to 
making the disclosure).

     (b)  ARBITRATION OF DISPUTES; LEGAL FEES.  Any dispute arising under this 
Stock Purchase Agreement shall be submitted by the parties to binding 
arbitration pursuant to the Tennessee Uniform Arbitration Act, with any such 
arbitration proceeding being conducted in accordance with the rules of the 
American Arbitration Association.  Any arbitration panel presiding over any 
arbitration proceeding hereunder is hereby empowered to render a decision in 
respect of such dispute, to award costs and expenses (including reasonable 
attorney fees) as it shall deem equitable and to enter its award in any court 
of competent jurisdiction.  Each of the Parties submits to the jurisdiction of 
any state or federal court sitting in Memphis, Shelby County, Tennessee for 
purposes of enforcement of any arbitration award hereunder.  Each Party also 
agrees not to bring any action or proceeding arising out of or relating to this 
Agreement in any other court.  Each of the Parties waives any defense of 
inconvenient forum to the maintenance of any action or proceeding so brought 
and waives any bond, surety, or other security that might be required of any 
other Party with respect thereto.  

     (c)  LIQUIDATED DAMAGES.  In the event that the Sellers shall be willing, 
ready and able to close on the Closing Date and the Purchaser shall fail to 
close on such date, the Purchaser shall pay to the Sellers, as liquidated 
damages and in complete satisfaction of all claims that Sellers may have 
against the Purchaser on account of said failure, the amount of $250,000.00, 
which shall be payable within ten (10) business days after such failure shall 
occur, and such reasonable attorneys' fees as shall have been incurred by the 
Sellers or the Group in connection with this Agreement.

     (d)  NO THIRD-PARTY BENEFICIARIES.  This Agreement shall not confer any 
rights or remedies upon any Person other than the Parties and their respective 
successors and permitted assigns.

     (e)  ENTIRE AGREEMENT.  This Agreement (including the documents referred 
to herein) constitutes the entire agreement among the Parties and supersedes 
any prior understandings, agreements, or representations by or among the 
Parties, written or oral, to the extent they related in any way to the subject 
matter hereof.

     (f)  SUCCESSION AND ASSIGNMENT.  This Agreement shall be binding upon and 
inure to the benefit of the Parties named herein and their respective 
successors and permitted assigns.  No Party may assign either this Agreement or 
any of his or its rights, interests, or obligations hereunder without the prior 
written approval of the Purchaser and the Seller; provided, however, that the 
Purchaser may (i) assign any or all of its rights and interests hereunder to 
one or more of its Affiliates and (ii) designate one or more of its Affiliates 
to perform its obligations hereunder (in any or all of which cases the 
Purchaser nonetheless shall remain responsible for the performance of all of 
its obligations hereunder).

     (g)  COUNTERPARTS.  This Agreement may be executed in one or more 
counterparts, each of which shall be deemed an original but all of which 
together will constitute one and the same instrument.

     (h)  HEADINGS.  The section headings contained in this Agreement are 
inserted for convenience only and shall not affect in any way the meaning or 
interpretation of this Agreement.

     (i)  NOTICES.  All notices, requests, demands, claims, and other 
communications hereunder will be in writing.  Any notice, request, demand, 
claim, or other communication hereunder shall be deemed duly given if (and then 
two business days after) it is sent by registered or certified mail, return 
receipt requested, postage prepaid, and addressed to the intended recipient as 
set forth below:

     If to the Seller:                   Copy to:

     Leonard Kalman, M.D.                Alan R. Chase, Esq.
     Oncology Hematology Group           Cohen, Chase, Hoffman & Trautman, P.A.
       of South Florida, P.A.            Suite 600, 9400 South Dadeland Blvd
     8940 N. Kendall Dr.,                Miami, Florida  33156
     Suite 300-E East Tower
     Miami, Florida 33176


     If to the Purchaser:                Copy to:

     Daryl P. Johnson                    John A. Good, Esq.
     Response Oncology, Inc.             Baker, Donelson, Bearman & Caldwell
     1775 Moriah Woods Blvd.             200 First Tennessee Building
     Memphis, Tennessee 38117            Memphis, Tennessee 38103


Any Party may send any notice, request, demand, claim, or other communication 
hereunder to the intended recipient at the address set forth above using any 
other means (including personal delivery, expedited courier, messenger service, 
telecopy, telex, ordinary mail, or electronic mail), but no such notice, 
request, demand, claim, or other communication shall be deemed to have been 
duly given unless and until it actually is received by the intended recipient.  
Any Party may change the address to which notices, requests, demands, claims, 
and other communications hereunder are to be delivered by giving the other 
Parties notice in the manner herein set forth.

     (j)  GOVERNING LAW.  This Agreement shall be governed by and construed in 
accordance with the domestic laws of the State of Tennessee without giving 
effect to any choice or conflict of law provision or rule (whether of the State 
of Tennessee or any other jurisdiction) that would cause the application of the 
laws of any jurisdiction other than the State of Tennessee.

     (k)  AMENDMENTS AND WAIVERS.  No amendment of any provision of this 
Agreement shall be valid unless the same shall be in writing and signed by the 
Purchaser and the Sellers.  No waiver by any Party of any default, 
misrepresentation, or breach of warranty or covenant hereunder, whether 
intentional or not, shall be deemed to extend to any prior or subsequent 
default, misrepresentation, or breach of warranty or covenant hereunder or 
affect in any way any rights arising by virtue of any prior or subsequent such 
occurrence.

     (l)  SEVERABILITY.  Any term or provision of this Agreement that is 
invalid or unenforceable in any situation in any jurisdiction shall not affect 
the validity or enforceability of the remaining terms and provisions hereof or 
the validity or enforceability of the offending term or provision in any other 
situation or in any other jurisdiction.

     (m)  EXPENSES.  Each of the Parties will bear his or its own costs and 
expenses (including legal fees and expenses) incurred in connection with this 
Agreement and the transactions contemplated hereby.  The Sellers agree that 
neither the Association has not borne or will not bear any of the Sellers' 
costs and expenses (including any of their legal fees and expenses) in 
connection with this Agreement or any of the transactions contemplated hereby.

     (n)  CONSTRUCTION.  The Parties have participated jointly in the 
negotiation and drafting of this Agreement.  In the event an ambiguity or 
question of intent or interpretation arises, this Agreement shall be construed 
as if drafted jointly by the Parties and no presumption or burden of proof 
shall arise favoring or disfavoring any Party by virtue of the authorship of 
any of the provisions of this Agreement.  Any reference to any federal, state, 
local, or foreign statute or law shall be deemed also to refer to all rules and 
regulations promulgated thereunder, unless the context requires otherwise.  The 
word "including" shall mean including without limitation.  The Parties intend 
that each representation, warranty, and covenant contained herein shall have 
independent significance.  If any Party has breached any representation, 
warranty, or covenant contained herein in any respect, the fact that there 
exists another representation, warranty, or covenant relating to the same 
subject matter (regardless of the relative levels of specificity) which the 
Party has not breached shall not detract from or mitigate the fact that the 
Party is in breach of the first representation, warranty, or covenant.

     (o)  INCORPORATION OF EXHIBITS AND SCHEDULES.  The Exhibits and Schedules 
identified in this Agreement are incorporated herein by reference and made a 
part hereof.

     (p)  SPECIFIC PERFORMANCE.  Each of the Parties acknowledges and agrees 
that the other Parties would be damaged irreparably in the event any of the 
provisions of this Agreement are not performed in accordance with their  
specific terms or otherwise are breached.  Accordingly, each of the Parties 
agrees that the other Parties shall be entitled to an injunction or injunctions 
to prevent breaches of the provisions of this Agreement and to enforce 
specifically this Agreement and the terms and provisions hereof in any action 
instituted in any court of the United States or any state thereof having 
jurisdiction over the Parties and the matter, in addition to any other remedy 
to which they may be entitled, at law or in equity.

                                *   *   *   *   *

     IN WITNESS WHEREOF, the Parties hereto have executed this Agreement on [as 
of] the date first above written.


                             PURCHASER:

                             Response Oncology, Inc.


                             By:__________________________________
                             Title:_______________________________


                             GROUP:

                             South Florida Oncology Hematology Associates, P.A.


                             By:__________________________________
                             Title:_______________________________

                             SELLERS:


                             _____________________________________
                             Dr. Leonard Kalman, individually and as
                             duly-authorized attorney-in-fact




                           Exhibit 2(b)(i)
                                  to
                      Stock Purchase Agreement

                   NON-NEGOTIABLE PROMISSORY NOTE

$5,959,972.00                                                Miami, Florida
                                                             January 2, 1996


     FOR VALUE RECEIVED, the undersigned, RESPONSE ONCOLOGY, INC., a Tennessee 
corporation (the "Maker"), promises to pay to the order of DR. LEONARD KALMAN, 
a resident of the State of Florida, individually and acting as attorney-in-fact 
for all Selling Shareholders pursuant to that certain Agreement among Selling 
Shareholders of even date herewith (the "Lender"), the principal sum of FIVE 
MILLION NINE HUNDRED FIFTY-NINE THOUSAND NINE HUNDRED SEVENTY-TWO DOLLARS 
($5,959,972.00), together with interest from date until maturity at the rate of 
nine (9%) percent per annum from date until Maturity (hereinafter defined), 
said principal and interest being payable in fifty nine (59) consecutive, 
equal, quarterly amortized installments of ONE HUNDRED EIGHTY-TWO THOUSAND 
SEVEN HUNDRED THIRTEEN AND FIFTY-FOUR ONE HUNDREDTHS DOLLARS ($182,713.54), 
commencing April 1, 1996, and on the first day of each calendar quarter 
thereafter.  The entire remaining unpaid balance of principal, and any accrued 
interest thereon, shall be due and payable on January 1, 2011.

     This Note may be prepaid in whole or in part prior to Maturity only with 
the advance written consent of the Lender.  Any partial prepayment of principal 
shall, however, not have the effect of suspending or deferring the payments 
provided for herein, but the same shall continue to be due and payable on each 
due date subsequent to any such partial prepayment of the principal and shall 
operate to effect full payment of the principal at an earlier date.

     At the option of the Lender, exercisable not later than ten (10) days 
prior to any payment of principal or interest on this Note, such payment shall 
be paid in whole or in part in shares of common stock of the Maker, $.01 par 
value per share (the "Shares").  For purposes of this paragraph, the number of 
Shares to which the Lender shall be entitled upon exercise of the option 
provided hereunder shall be determined by dividing the amount of principal and 
interest to be paid in Shares by the Maker by $17.50, which price shall be 
adjusted for stock splits, stock dividends, reverse stock splits, 
recapitalizations, reorganizations and other changes in the capital structure 
of the Maker affecting the value of the Shares.

     Any amounts not paid when due hereunder (whether by acceleration or 
otherwise) shall bear interest after maturity at the lesser of (a) eighteen 
percent (18%) per annum or (b) the maximum effective contract rate which may be 
charged by the Lender under applicable law from time to time in effect.

     In the event that the foregoing provisions should be construed by a court 
of competent jurisdiction not to constitute a valid, enforceable designation of 
a rate of interest or method of determining same, the indebtedness hereby 
evidenced shall bear interest at the maximum effective contract rate which may 
be charged by the Lender under applicable law from time to time in effect.

     This Note is non negotiable.

     Notwithstanding anything to the contrary, the payments required pursuant 
to this Note are subject to a right of offset, setoff, and recoupment as a 
result of any indemnification required pursuant to the provisions of that 
certain Stock Purchase Agreement by and between Lender and Maker dated as of 
December ___, 1995.

     All installments of interest, and the principal hereof, are payable by 
Maker's corporate check at ______________________________ or at such other 
place as the holder may designate in writing, in lawful money of the United 
States of America, which shall be legal tender in payment of all debts and 
dues, public and private, at the time of payment.

     If the Maker shall fail to make payment of any installment of principal 
and interest, as above provided, and such failure shall continue unremedied for 
a period of thirty (30) days following written notice thereof, or upon the 
dissolution of the Maker or any endorser, and (if there is a cure period 
applicable thereto) such default is not cured within such applicable cure 
period, then and in any such event, the entire unpaid principal balance of the 
indebtedness evidenced hereby, together with all interest then accrued, shall, 
at the absolute option of the holder hereof, at once become due and payable, 
without demand or notice, the same being hereby expressly waived.

     If this Note is placed in the hands of an attorney for collection, by suit 
or otherwise, the Maker shall pay on demand all costs of collection and 
litigation (including court costs), together with a reasonable attorney's fee 
if Lender is successful in the litigation.

     It is the intention of the Lender and the Maker to comply strictly with 
applicable usury laws; and, accordingly, in no event and upon no contingency 
shall the holder hereof ever be entitled to receive, collect, or apply as 
interest any interest, fees, charges or other payments equivalent to interest, 
in excess of the maximum effective contract rate which the Lender may lawfully 
charge under applicable statutes and laws from time to time in effect; and in 
the event that the holder hereof ever receives, collects, or applies as 
interest any such excess, such amount which, but for this provision, would be 
excessive interest, shall be applied to the reduction of the principal amount 
of the indebtedness hereby evidenced; and if the principal amount of the 
indebtedness evidenced hereby, all lawful interest thereon and all lawful fees 
and charges in connection therewith, are paid in full, any remaining excess 
shall forthwith be paid to the Maker, or other party lawfully entitled thereto. 
All interest paid or agreed to be paid by the Maker shall, to the maximum 
extent permitted under applicable law, be amortized, prorated, allocated and 
spread throughout the full period until payment in full of the principal so 
that the interest hereon for such full period shall not exceed the maximum 
amount permitted by applicable law.  Any provision hereof, or of any other 
agreement between the holder hereof and the Maker, that operates to bind, 
obligate, or compel the Maker to pay interest in excess of such maximum 
effective contract rate shall be construed to require the payment of the 
maximum rate only.  The provisions of this paragraph shall be given precedence 
over any other provision contained herein or in any other agreement between the 
holder hereof and the Maker that is in conflict with the provisions of this 
paragraph.

     Neither Lender, nor any subsequent holder of this Note, shall have any 
right to commute, sell, assign, transfer or otherwise convey the right to 
receive any payments hereunder (except to the Maker, or to ONCOLOGY HEMATOLOGY 
GROUP OF SOUTH FLORIDA, P.A. [the "P.A."]), which payments and the rights 
thereto are hereby expressly declared: (i) to be nonassignable and non-
transferrable (except to the Maker or to the P.A.), and (ii) not liable for or 
subject to the debts, liabilities, or obligations or the Lender or the P.A. 
(except for those debts, obligations and liabilities of the P.A. to Maker which 
are secured by the security interest in this Note granted to Maker pursuant to 
a security agreement of even date herewith; and, in the event of any attempted 
assignment or transfer (except to the Maker or to the P.A.), the Maker shall 
have no further liability under this Note.

     This Note shall be governed and construed according to the statutes and 
laws of the State of Tennessee from time to time in effect.

                                   RESPONSE ONCOLOGY, INC.

                                   By:_____________________________________
                                   Title:__________________________________



                             Exhibit 2(b)(ii)
                                    to
                        Stock Purchase Agreement

                      COMMON STOCK PURCHASE WARRANT

                                                    Certificate No. SF-Specimen

This Warrant has not been registered under the Securities Act of 1933 or any 
state securities law, has been acquired for investment only and may not be 
sold, transferred, assigned, pledged, hypothecated or otherwise disposed of 
unless it has been registered under the Securities Act of 1933 and any 
applicable state securities law, or the proposed transfer is exempt from the 
registration requirements of the Securities Act of 1933 and any applicable 
state securities law.

____________________________________________________________________________

                     WARRANT TO PURCHASE COMMON STOCK  

                                   OF

                         RESPONSE ONCOLOGY, INC. 
____________________________________________________________________________

     This Warrant is granted as of January 2, 1996 by Response Oncology, Inc., 
a Tennessee corporation (the "Issuer"), which certifies that, for value 
received, the registered holder hereof, or his registered assigns (the 
registered holder or assigns are referred to herein as the "Holder"), is 
entitled to purchase from the Issuer, at any time and from time to time during 
the Exercise Period (as hereinafter defined) at the Exercise Price (as 
hereinafter defined) per share (as adjusted as herein provided), 160,000 shares 
of common stock (the "Common Stock") of Response Oncology, Inc. (the "Company") 
(such number of shares of Common Stock purchasable upon the exercise of this 
Warrant to Purchase Common Stock, as adjusted from time to time pursuant to the 
provisions hereinafter set forth, are referred to in this Warrant as the 
"Warrant Shares").  This Warrant has been issued in connection with and as 
partial consideration for the acquisition (the "Stock Purchase") by the Issuer 
of all of the outstanding shares of capital stock of Oncology Hematology Group 
of South Florida, P.A. (the "Association") pursuant to that certain Stock 
Purchase Agreement dated as of December 20, 1995 among the Issuer and the 
stockholders of the Association.

     VOID AFTER 5:00 P.M. MEMPHIS, TENNESSEE TIME, ON DECEMBER 31, 2000,
     SUBJECT TO EARLIER TERMINATION AS HEREINAFTER SET FORTH
      This Warrant is subject to the following terms and conditions:

     1.  EXERCISE PERIOD.  The period in which the Holder shall have the right 
to exercise this Warrant (the "Exercise Period") shall commence on the date 
hereof and shall terminate on (the "Termination Date") the earlier of (i) 
December 31, 2000, (ii) the occurrence of any merger, voluntary dissolution or 
other event pursuant to which the existence of the Issuer shall terminate, or 
(iii) thirty (30) days following the occurrence of any Oncology Event of 
Default as defined in that certain Service Agreement between the Issuer and 
Oncology Hematology Group of South Florida, P.A. dated as of January 2, 1996 
(taking into account, for purposes of determining the date of occurrence of 
such Oncology Event of Default, any curative period).

     2.  EXERCISE PRICE.  The Exercise Price shall be equal to $12.50 per 
share.   The Exercise Price is subject to adjustment as provided in Section 5 
below.

     3.  TERMINATION OF WARRANTS.  The Warrants shall terminate on the 
Termination Date and shall not be exercisable thereafter.

     4.  EXERCISE OF WARRANTS. (a) The Warrants may be exercised in whole or in 
part, at any time and from time to time, during the Exercise Period by 
surrendering this Warrant, with the purchase form provided for herein duly 
executed by the Holder or by the Holder's duly authorized attorney-in-fact, at 
the principal office of the Issuer or at such other office in the United States 
as the Issuer may designate by notice in writing to the Holder (the "Issuer's 
Office") accompanied by payment of the Exercise Price in full, in cash or by 
certified or cashier's check, payable to the order of the Issuer, or, at the 
option of the Holder, by wire transfer in accordance with instructions provided 
by the Issuer.  If fewer than all of the Warrants are exercised, the Issuer 
shall, upon each exercise prior to the expiration of the Exercise Period, 
execute and deliver to the Holder an amendment to this Warrant (dated the date 
hereof) evidencing the balance of the Warrants that remain exercisable.

     (b)  On the date of exercise of the Warrant, the Holder exercising the 
same shall be deemed to have become the holder of record for all purposes of 
the Warrant Shares to which the exercise relates.

     (c)  As soon as practicable, but not later than ten (10) days after the 
exercise of all or part of the Warrants, the Issuer shall, at the Issuer's 
expense (including the payment of any applicable issue taxes and the cost of 
any opinion of counsel required by the Issuer or its transfer agent), cause to 
be issued in the name of and delivered to the Holder a certificate or 
certificates evidencing the number of fully paid and nonassessable Warrant 
Shares to which the Holder shall be entitled upon such exercise.

     (d)  The Warrant Shares issued upon exercise of this Warrant will not be 
registered under the Securities Act of 1933, as amended (the "Act") or the 
securities laws of any state in reliance on exemptions from the registration 
requirements of the Act and such laws.  Accordingly, the Warrant Shares may be 
sold or otherwise transferred only upon (i) registration under the Act and 
qualification under applicable state securities laws, (ii) compliance with Rule 
144 under the Act, or (iii) the Issuer's receipt of an opinion, at the Holder's 
expense, from counsel reasonable acceptable to the Issuer to the effect that 
any such sale or transfer will not violate the Act or any state law.  The 
Issuer will cause an appropriate legend to be placed on certificates 
representing the Warrant Shares to the foregoing effect.

     5.  ADJUSTMENTS OF EXERCISE PRICE, NUMBER AND CHARACTER OF WARRANT SHARES, 
AND NUMBER OF WARRANTS.  The Exercise Price, the number and kind of securities 
purchasable upon the exercise of each Warrant, and the number of Warrants 
outstanding shall be subject to adjustment from time to time upon the happening 
of the events enumerated in this Section 5.

     (a)  In case the Issuer shall at any time on or after the date hereof (i) 
pay a dividend in shares of Common Stock or other securities of the Issuer or 
make a distribution in shares of Common Stock or such other securities to 
holders of all its outstanding shares of Common Stock, (ii) subdivide or 
reclassify the outstanding shares of Common Stock into a greater number of 
shares, (iii) combine the outstanding shares of Common Stock into a smaller 
number of shares of Common Stock, or (iv) issue by reclassification of its 
shares of Common Stock other securities of the Issuer (including any such 
reclassification in connection with a consolidation or merger in which the 
Issuer is the continuing corporation), then the number and kind of Warrant 
Shares purchasable upon exercise of each Warrant outstanding immediately prior 
thereto shall be adjusted so that the Holder shall be entitled to receive the 
kind and number of shares of Common Stock or other securities of the Issuer 
which the Holder would have owned or have been entitled to receive after the 
happening of any of the events described above had such Warrant been exercised 
in full immediately prior to the earlier of the happening of such event or any 
record date in respect thereof.  In the event of any adjustment of the total 
number of shares of Common Stock purchasable upon the exercise of the then 
outstanding Warrants pursuant to this Section 5(a), the Exercise Price shall be 
adjusted to be the amount resulting from dividing the number of shares of 
Common Stock (including fractional shares of Common Stock) covered by such 
Warrant immediately after such adjustment into the total amount payable upon 
exercise of such Warrant in full immediately prior to such adjustment.  An 
adjustment made pursuant to this Section 5(a) shall become effective 
immediately after the effective date of such event retroactive to the record 
date for any such event.  Such adjustment shall be made successively whenever 
any event listed above shall occur.

     (b)  In case the Issuer shall at any time after the date hereof fix a 
record date for the issuance of rights, options, or warrants to all holders of 
its outstanding shares of Common Stock, entitling them (for a period expiring 
within forty-five (45) days after such record date) to subscribe for or 
purchase shares of Common Stock (or securities exchangeable for or convertible 
into shares of Common Stock) at a price per common share (or having an exchange 
or conversion price per common share, with respect to a security exchangeable 
for or convertible into shares of Common Stock) which is lower than the 
Exercise Price per common share on such record date, then the Exercise Price 
shall be adjusted by multiplying the Exercise Price in effect immediately prior 
to such record date by a fraction, of which the numerator shall be the number 
of shares of Common Stock outstanding on such record date plus the number of 
shares of Common Stock which the aggregate offering price of the total number 
of shares of Common Stock so to be offered (or the aggregate initial exchange 
or conversion price of the exchangeable or convertible securities so to be 
offered) would purchase at such current Exercise Price and of which the 
denominator shall be the number of shares of Common Stock outstanding on such 
record date plus the number of additional shares of Common Stock to be offered 
for subscription or purchase (or into which the exchangeable or convertible 
securities so to be offered are initially exchangeable or convertible).  Such 
adjustment shall become effective at the close of business on such record date; 
however, to the extent that shares of Common Stock (or securities exchangeable 
for or convertible into shares of Common Stock) are not delivered after the 
expiration of such rights, options, or warrants, the Exercise Price shall be 
readjusted (but only with respect to Warrants exercised after such expiration) 
to the Exercise Price which would then be in effect had the adjustments made 
upon the issuance of such rights, options, or warrants been made upon the basis 
of delivery of only the number of shares of Common Stock (or securities 
exchangeable for or convertible into shares of Common Stock) actually issued.  
In case any subscription price may be paid in a consideration part or all of 
which shall be in a form other than cash, the value of such consideration shall 
be as determined in good faith by the Board of Directors of the Issuer and 
shall be described in a statement mailed to the Holder.  Shares of Common Stock 
owned by or held for the account of the Issuer shall not be deemed outstanding 
for the purpose of any such computation.

     (c)  In case the Issuer shall at any time after the date hereof distribute 
to all holders of its shares of Common Stock (including any such distribution 
made in connection with a consolidation or merger in which the Issuer is the 
surviving corporation) evidences of its indebtedness or assets (excluding cash 
dividends and distributions payable out of consolidated net income or earned 
surplus in accordance with applicable law and dividends or distributions 
payable in shares of stock described in Section 5(a) above) or rights, options, 
or warrants or exchangeable or convertible securities containing the right to 
subscribe for or purchase shares of Common Stock (or securities exchangeable 
for or convertible into shares of Common Stock) (excluding those expiring 
within forty-five (45) days after the record date referred to in Section 5(b) 
above), then the Exercise Price shall be adjusted by multiplying the Exercise 
Price in effect immediately prior to the record date for such distribution by a 
fraction, of which the numerator shall be the fair market value of the shares 
of Common Stock on such day, as determined in good faith by the Board of 
Directors of the Issuer whose determination shall be conclusive, and described 
in a notice to the Holder of the portion of the evidences of indebtedness or 
assets so to be distributed or of such rights, options or warrants applicable 
to one common share and of which the denominator shall be such fair market 
value per common share.  Such adjustment shall be made whenever any such 
distribution is made, and shall become effective on the date of distribution 
retroactive to the record date for such transaction.

     (d)  For the purpose of this Warrant, the fair market value per share of 
Common Stock shall be determined by reference to the latest independent bid for 
the Common Stock as set forth in the National Market of The Nasdaq Stock Market 
or, if the Common Stock shall be traded on any national or regional securities 
exchange, the latest bid price for the Common Stock, or, if none of the 
foregoing apply, as determined in good faith by the Board of Directors of the 
Issuer.

     (e)  No adjustment in the Exercise Price or the number of Warrant Shares 
purchasable shall be required unless such adjustment would require an increase 
or decrease of at least ten percent (10%) in the Exercise Price or the number 
of Warrant Shares purchasable; provided, however, that any adjustments which by 
reason of this Section 5(e) are not required to be made (i) shall be carried 
forward and taken into account in any subsequent adjustment or (ii) if no 
subsequent adjustment occurs, shall be made immediately prior to exercise of 
this Warrant.  All calculations under this Section 5 shall be made to the 
nearest cent or to the nearest one-hundredth of a share, as the case may be.

     (f)  Unless the Issuer shall have exercised its election as provided in 
Section 5(g), upon each adjustment of the Exercise Price as a result of the 
calculations made in Sections 5(b) or (c), each Warrant outstanding prior to 
the making of the adjustment in the Exercise Price shall thereafter evidence 
the right to purchase, at the adjusted Exercise Price, that number of shares of 
Common Stock (calculated to the nearest hundredth) obtained by (i) multiplying 
the number of shares of Common Stock purchasable upon exercise of a Warrant 
prior to adjustment of the number of shares of Common Stock by the Exercise 
Price in effect prior to adjustment of the Exercise Price and (ii) dividing the 
product so obtained by the Exercise Price in effect after such adjustment of 
the Exercise Price.

     (g)  The Issuer may elect on or after the date of any adjustment of the 
Exercise Price to adjust the number of Warrants, in substitution for any 
adjustment in the number of Warrant Shares purchasable upon the exercise of 
Warrants as provided in Sections 5(a) and (f).  Each of the Warrants 
outstanding after such adjustment of the number of Warrants shall be 
exercisable for one share of Common Stock.  Each Warrant held of record prior 
to such adjustment of the number of Warrants shall become that number of 
Warrants (calculated to the nearest hundredth) obtained by dividing the 
Exercise Price in effect prior to adjustment of the Exercise Price by the 
Exercise Price in effect after adjustment of the Exercise Price.  The Issuer 
shall send to each Holder a notice of its election to adjust the number of 
Warrants, indicating the record date for the adjustment, and if known at the 
time, the amount of the adjustment to be made.  This record date may be the 
date on which the Exercise Price is adjusted or any day thereafter, but shall 
be at least ten (10) days after the date such announcement is sent to the 
Holders.  Upon each adjustment of the number of Warrants pursuant to this 
Section 5(g) the Issuer shall, as promptly as practicable, cause to be 
distributed to holders of record of Warrants on such record date new 
certificate(s) evidencing the additional Warrants to which such holders shall 
be entitled as a result of such adjustment, or, at the option of the Issuer, 
shall cause to be distributed to such holders of record in substitution and 
replacement for the certificates held by such holders prior to the date of 
adjustments, and upon surrender thereof if required by the Issuer, new 
certificates evidencing all the Warrants to which such holders shall be 
entitled after such adjustment.

     (h)  In case of any capital reorganization of the Issuer, or of any 
reclassification of the shares of Common Stock [other than a reclassification, 
subdivision or combination of shares of Common Stock referred to in Section 
5(a)], or in case of the consolidation of the Issuer with, or the merger of the 
Issuer with, or merger of the Issuer into, any other corporation, limited 
partnership, limited liability company or other business entity (other than a 
reclassification of the shares of Common Stock referred to in Section 5(a) or a 
consolidation or merger which does not result in any reclassification or change 
of the outstanding shares of Common Stock) or of the sale of the properties and 
assets of the Issuer as, or substantially as, an entirety to any other 
corporation or entity, each Warrant shall after such capital reorganization, 
reclassification of shares of Common Stock, consolidation, merger, or sale be 
exercisable, upon the terms and conditions specified in this Warrant, for the 
kind, amount and number of shares or other securities, assets, or cash to which 
a holder of the number of shares of Common Stock purchasable (at the time of 
such capital reorganization, reclassification of shares of Common Stock, 
consolidation, merger or sale) upon exercise of such Warrant would have been 
entitled to receive upon such capital reorganization, reclassification of 
shares of Common Stock, consolidation, merger, or sale; and in any such case, 
if necessary, the provisions set forth in this Section 5 with respect to the 
rights and interests thereafter of the holders of the Warrants shall be 
appropriately adjusted so as to be applicable, as nearly equivalent as 
possible, to any shares or other securities, assets, or cash thereafter 
deliverable on the exercise of the Warrants.  The subdivision or combination of 
shares of Common Stock at any time outstanding into a greater or lesser number 
of shares shall not be deemed to be a reclassification of the shares of Common 
Stock for purposes of this Section 5(h).

     (i)  In the event that at any time, as a result of an adjustment made 
pursuant to this Section 5, the holders of an Warrant or Warrants shall become 
entitled to purchase any shares or securities of the Issuer other than the 
shares of Common Stock, thereafter the number of such other shares or 
securities so purchasable upon exercise of each Warrant and the exercise price 
for such shares or securities shall be subject to adjustment from time to time 
in a manner and on terms as nearly equivalent as possible to the provisions 
with respect to the shares of Common Stock contained in Sections 5(a) through 
(h), inclusive.

     (j)  In any case in which this Section 5 shall require that an adjustment 
in the Exercise Price be made effective as of a record date for a specified 
event, the Issuer may elect to defer until the occurrence of such event issuing 
to the holder of any Warrant exercised after such record date the shares of 
Common Stock, if any, issuable upon such exercise over and above the Warrant 
Shares, if any, issuable upon such exercise on the basis of the Exercise Price 
in effect prior to such adjustment; provided, however, that the Issuer shall 
deliver as soon as practicable to such holder a due bill or other appropriate 
instrument provided by the Issuer evidencing such holder's right to receive 
such additional shares of Common Stock upon the occurrence of the event 
requiring such adjustment.

     (k)  Notwithstanding anything herein to the contrary, no adjustment shall 
be required under this Section 5 in the event the Issuer (i) issues options to 
purchase Common Stock or other securities to officers, directors, employees or 
agents pursuant to an incentive or non-qualified stock option plan, or (ii) 
issues shares of Common Stock or other securities pursuant to an offering for 
cash or other consideration (including the assets or capital stock or 
securities of any other corporation or other business entity), or pursuant to a 
plan of merger whereby the Issuer is the surviving participant in the merger, 
other than an issuance of rights, options or warrants exercisable for shares of 
Common Stock (or securities exchangeable for or convertible into shares of 
Common Stock) to all holders of its outstanding shares of Common Stock.

      6.  DEFINITION OF SHARES OF COMMON STOCK.  The shares of Common Stock 
issuable upon exercise of the Warrants shall be the shares of Common Stock as 
constituted on the date hereof except as otherwise provided in Section 5.

     7.  NOTICE OF NUMBER OF WARRANT SHARES, ADJUSTMENT OR TERMINATION.  Within 
thirty (30) days of the occurrence of an event which results in an adjustment 
in the number of Warrants, the number of Warrant Shares purchasable upon the 
exercise of Warrants and/or the Exercise Price or the termination of the 
Warrants shall have occurred as provided herein, the Issuer shall forthwith:

     (a)  prepare and hold for inspection at the Issuer's principal place of 
business, 1775 Moriah Woods Blvd., Memphis, Tennessee 38117, or such subsequent 
principal place of business (the "Issuer's Office"), a statement, signed by the 
Chief Financial Officer of the Issuer, stating either (i) the number of 
Warrants or Warrant Shares, (ii) the adjusted number of Warrants or Warrant 
Shares purchasable upon the exercise of Warrants and/or Exercise Price 
determined as herein provided, such statement to show in detail the facts 
requiring such adjustment or (iii) the termination of the Warrants, and

     (b)  give notice embodying such statement to each Holder as provided in 
Section 13.  Where appropriate, such notice may be given in advance and may be 
included as part of a notice required to be mailed pursuant to Section 8.

     8.  NOTICES OF RECORD DATE, ETC.  In the event the Issuer shall propose to 
take any action of the type requiring an adjustment of the Exercise Price or 
the number or character of the Warrant Shares or Warrants pursuant to Section 5 
or a dissolution, liquidation or winding up of the Issuer (other than in 
connection with a consolidation, merger, or sale of all or substantially all of 
its property, assets, and business as an entirety) shall be proposed, the 
Issuer shall give notice to each Holder as provided in Section 13, which notice 
shall specify the record date, if any, with respect to any such action and the 
date on which such action is to take place.  Such notice shall also set forth 
such facts with respect thereto as shall be reasonably necessary to indicate 
the effect of such action (to the extent such effect may be known at the date 
of such notice) on the Exercise Price and the number, kind or class of shares 
or other securities or property which shall be deliverable or purchasable upon 
the occurrence of such action or deliverable upon the exercise of the Warrants. 
In the case of any action which will require the fixing of a record date, 
unless otherwise provided in this Warrant, such notice shall be given at least 
twenty (20) days prior to the date so fixed, and in case of all other action, 
such notice shall be given at least thirty (30) days prior to the taking of 
such proposed action.

     9.  REPLACEMENT OF SECURITIES.  If this Warrant shall be lost, stolen, 
mutilated or destroyed, the Issuer shall, on such terms as to indemnity or 
otherwise as the Issuer may in its discretion reasonably impose, issue a new 
certificate of like tenor or date representing in the aggregate the right to 
subscribe for and purchase the number of shares of Common Stock which may be 
subscribed for and purchased hereunder.  Any such new certificate shall 
constitute an original contractual obligation of the Issuer, whether or not the 
allegedly lost, stolen, mutilated or destroyed Warrant shall be at any time 
enforceable by anyone.

     10.  RECORDKEEPING.  This Warrant, as well as all other warrant 
certificates representing Warrants of like tenor issued in connection with the 
Stock Purchase shall be numbered beginning with the alphabetic prefix "SF" and 
shall be registered in a register (the "Warrant Register") maintained at the 
Issuer's Office as they are issued.  The Warrant Register shall list the name, 
address and Social Security or other Federal Identification Number, if any, of 
all Holders.  Upon notice duly given by the Holder, the Issuer shall be 
entitled to recognize the Holder as set forth in the Warrant Register as the 
nominee for the beneficial owners of the Warrants as set forth in such notice 
or subsequent notices with respect to such beneficial ownership recognize for 
all purposes and shall not be bound to recognize any equitable or other claim 
to or interest in such Warrant on the part of any other person, and shall not 
be liable for any registration of transfer of Warrants that are registered or 
to be registered in the name of a fiduciary or the nominee of a fiduciary 
unless made with the actual knowledge that a fiduciary or nominee is committing 
a breach of trust in requesting such registration of transfer, or with such 
knowledge of such facts that its participation therein amounts to bad faith.

     11.  TRANSFER. This Warrant shall not be transferable and may not be the 
subject of a sale, assignment, pledge or other conveyance without the Issuer's 
advance consent, which the Issuer may withhold in its absolute discretion.  The 
Warrant shall be transferable only on the Warrant Register upon delivery of 
such Warrants, with the assignment form provided for herein duly executed by 
the Holder or by the Holder's duly authorized attorney-in-fact.  Upon any 
registration of transfer, the Issuer shall execute and deliver a new Warrant 
certificate to the person entitled thereto.

     The Warrants have not been registered under the Securities Act of 1933 or 
any state securities law, and, accordingly, may not be sold, transferred, 
assigned, pledged, hypothecated or otherwise disposed of unless they have been 
registered under the Securities Act of 1933 and any applicable state securities 
law or, in the opinion of counsel reasonably satisfactory to the Issuer, whose 
fees and expenses in connection with such opinion will be borne by the Holder, 
the proposed transfer is exempt from the registration requirements of the 
Securities Act of 1933 and any applicable state securities law.

     12.  EXCHANGE OF WARRANT CERTIFICATES.  This Warrant may be exchanged for 
another certificate or certificates entitling the Holder thereof to purchase a 
like aggregate number of Warrant Shares as this Warrant entitles such Holder to 
purchase.  A Holder desiring to so exchange this Warrant shall make such 
request in writing delivered to the Issuer, and shall surrender this Warrant 
therewith.  Thereupon, the Issuer shall execute and deliver to the person 
entitled thereto a new certificate or certificates, as the case may be, as so 
requested.

     13.  PIGGYBACK REGISTRATION.  

          (a)     NOTICE OF PIGGYBACK REGISTRATION AND INCLUSION OF WARRANT 
SHARES.

          If, after the Holder's exercise of the Warrants pursuant to Section 4 
hereof, the Issuer shall elect to file a registration statement ("Registration 
Statement") on Form S-2 or S-3 (or any successor form thereto) under the Act 
with respect to any of its securities, either for its own account or the 
account of a security holder or holders, other than a registration of a public 
offering of Common Stock commenced within one (1) year of the date hereof or a 
registration relating solely to employee benefit plans (excluding the foregoing 
events, a "Registration"), the Issuer will:  (i) promptly give each Holder 
written notice thereof (which shall include a list of the jurisdictions in 
which the Issuer intends to attempt to qualify such securities under the 
applicable Blue Sky or other state securities laws) and (ii) include in such 
Registration (and any related registration and/or qualification under Blue Sky 
laws or other compliance), and in any underwriting involved therein, all the 
Warrant Shares specified in a written request delivered to the Issuer by any 
Holder within 30 days after delivery of such written notice from the Issuer.

          (b)     UNDERWRITING IN PIGGYBACK REGISTRATION.

               (i)     NOTICE OF UNDERWRITING IN PIGGYBACK REGISTRATION.

               If  the Registration of which the Issuer gives notice is for a 
Registered public offering involving an underwriting, the Issuer shall so 
advise the Holders as a part of the written notice given pursuant to Section 
13(a).  In such event, the right of any Holder to Registration shall be 
conditioned upon such underwriting and the inclusion of such Holder's Warrant 
Shares in such underwriting to the extent provided in this Section 13.  All 
Holders proposing to distribute their securities through such underwriting 
shall (together with the Issuer and any other holders distributing their 
securities through such underwriting) enter into an underwriting agreement in 
customary form with the representative of the Underwriter ("Underwriter's 
Representative") for such offering.  The Holders shall have no right to 
participate in the selection of underwriters for an offering pursuant to this 
Section.

               (ii)     MARKETING LIMITATION IN PIGGYBACK REGISTRATION.

               In the event the Underwriter's Representative advises the 
Holders seeking Registration of Warrant Shares pursuant to Section 13 in 
writing that market factors (including, without limitation, the aggregate 
number of shares of Common Stock requested to be included in such Registration, 
the general condition of the market, and the status of the persons proposing to 
sell securities pursuant to the Registration) require a limitation of the 
number of shares to be underwritten, the Underwriter's Representative (subject 
to the allocation priority set forth in Section 13(a)(iii) may limit (or reduce 
to zero) the number of Warrant Shares to be included in such Registration and 
underwriting; provided however, that any Warrant Shares so excluded shall 
retain any and all Registration rights set forth in Section 13 hereof. 

               (iii)     ALLOCATION OF WARRANT SHARES IN PIGGYBACK 
REGISTRATION.

               In the event that the Underwriter's Representative limits the 
number of shares to be included in a Registration pursuant to Section 
13(a)(ii), the number of shares to be included in such Registration shall be 
allocated in the following manner:  Common Stock held by persons who are not 
contractually entitled to include shares in such Registration shall be excluded 
from such Registration and underwriting to the extent required by such 
limitation.  If a limitation of the number of shares is still required after 
such exclusion, the number of shares of Common Stock that may be included in 
the Registration and underwriting by all selling shareholders (including the 
Holders and all other persons contractually entitled to such registration) 
shall be allocated among Holders and other holders of securities other than 
Warrant Shares requesting and contractually entitled to include shares in such 
Registration, in proportion, as nearly as practicable, to the respective 
amounts of securities (including Warrant Shares) which such Holders and such 
other holders would otherwise be entitled to include in such Registration.  No 
Warrant Shares or other securities excluded from the underwriting by reason of 
this Section 13(a)(iii) shall be included in the Registration Statement.

               (iv)     WITHDRAWAL IN PIGGYBACK REGISTRATION.

               If any Holder disapproves of the terms of any such underwriting, 
he may elect to withdraw therefrom by written notice to the Issuer and the 
underwriter delivered at least seven days prior to the effective date of the 
Registration Statement.  Any Warrant Shares or other securities excluded or 
withdrawn from such underwriting shall be withdrawn from such Registration. 

          (c)     BLUE SKY IN PIGGYBACK REGISTRATION.

          In the event of any Registration of Warrant Shares pursuant to 
Section 13, the Issuer will use its best efforts to register and/or qualify the 
securities covered by the Registration Statement under such other securities or 
Blue Sky laws of such jurisdictions as shall be reasonably appropriate for the 
distribution of such securities; provided, however, that notwithstanding 
anything in this Agreement to the contrary, in the event any jurisdiction in 
which the securities shall be qualified imposes a non-waivable requirement that 
expenses incurred in connection with the qualification of the securities be 
borne by selling shareholders, the Holders shall pay their pro rata share of 
such expenses.

     14.  DEMAND REGISTRATION.

          (a)     REQUEST FOR REGISTRATION.

          Subject to exceptions as hereinafter provided, after the first 
anniversary of the Closing Date, the Holders which have exercised Warrants 
pursuant to Section 4 hereof (the "Unregistered Shares"), may annually make a 
single request (a "Demand") in writing within 30 days of the anniversary date 
that the Issuer file and effect a registration statement with the Commission in 
respect of all, but not less than all, shares of Unregistered Shares held by 
the Holders.  Upon receipt of a Demand, the Issuer shall as soon as practicable 
cause a Registration Statement to be filed with the Commission, which 
Registration Statement shall, if not an Underwritten Offering pursuant to 
Section 13 above, contain all appropriate undertakings necessary to comply with 
Rule 415 under the 1933 Act pertaining to "shelf registration", and the Issuer 
shall use its best efforts to effect such Registration (including the execution 
of an undertaking to file post effective amendments and any related 
registration or qualification under Blue Sky Laws or other compliance with the 
Securities Act) as may be so requested and as would permit or facilitate the 
sale and distribution of the Unregistered Shares.  
           (b) REGISTRATION OF OTHER SECURITIES IN DEMAND REGISTRATION.

          Any Registration Statement filed pursuant to the request of the 
Holders under this Section 14 may, subject to the provisions of Section 14(c), 
include securities of the Issuer other than the Unregistered shares.

          (c)     BLUE SKY IN DEMAND REGISTRATION.

          In the event of any Registration of Warrant Shares pursuant to 
Section 14, the Issuer will use its best efforts to register and/or qualify the 
securities covered by the Registration Statement under such other securities or 
Blue Sky laws of such jurisdictions as shall be reasonably appropriate for the 
distribution of such securities; provided, however, that notwithstanding 
anything in this Agreement to the contrary, in the event any jurisdiction in 
which the securities shall be qualified imposes a non-waivable requirement that 
expenses incurred in connection with the qualification of the securities be 
borne by selling shareholders, the Holders shall pay their pro rata share of 
such expenses.

          (d)     UNDERWRITTEN DEMAND REGISTRATION.

          The Holders making a Demand shall be entitled to engage an 
underwriter reasonably acceptable to the Issuer to offer and sell in a public 
offering the Unregistered Shares included in any Registration Statement filed 
pursuant to Section 14(a) above.  In such event, the Issuer and each 
participating Holder shall enter into an underwriting agreement in customary 
form with the representative of the underwriter ("Underwriter's 
Representative") for such offering.  Whether or not an underwriting agreement 
is entered into, the Issuer shall:

               (i)     make such representation and warranties to the Holders 
participating in such registration and the underwriters, if any, in form, 
substance and scope as are customarily made by issuers to underwriters in 
comparable underwritten offerings;

               (ii)     obtain opinions of counsel to the Issuer and updates 
thereof (which counsel and opinions (if form, scope and substance) shall be 
reasonably satisfactory to the Underwriter's Representative, if any, and the 
Holders of a majority in number of the Unregistered Shares being sold) 
addressed to such Holders and underwriters, if any, covering the matters 
customarily covered in opinions requested in underwritten offerings and such 
other matters as may be reasonably requested by such Holders and the 
underwriters, if any;

               (iii)     obtain comfort letters and updates thereof from the 
Issuer's independent certified public accountants addressed to the selling 
Holders and the underwriters, if any, such letters to be in customary form and 
covering matters of the type (including the "circling" of numbers in the 
prospectus included in the Registration Statement, with appropriate legends 
explaining the procedures performed with respect to "circled" numbers) 
customarily covered in comfort letters by independent certified public 
accountants in connection with underwritten offerings, on such date or dates as 
may be reasonably requested by the Underwriters' Representative and the Holders 
of a majority of the Unregistered Shares being sold; and

               (iv)     deliver such documents and certificates as may be 
reasonably requested by the Holders of a majority of the Unregistered Shares 
being sold and the Underwriters' Representative, if any, to evidence compliance 
with any customary conditions contained in the underwriting agreement.

     In connection with such Underwritten Offering, the Issuer shall (i) make 
provide to a single counsel for the Holders whose Unregistered Shares are 
included in such Underwritten Offering, for such counsel's review and comment, 
drafts of the Registration Statement; (ii) provide such counsel with a 
reasonable number of executed copies of the Registration Statement and all 
amendments thereto, as filed, as well as a reasonable number of preliminary 
prospectuses used by the underwriters in such Underwritten Offering; (iii) give 
prompt notice to such counsel of the effectiveness of such registration 
statement and of any stop order issued by the Commission or proceeding, or 
threat of such a proceeding, by the Commission for the purpose of issuing a 
stop order or otherwise suspending the effectiveness of any Registration 
Statement; (iv) provide to the Holders a reasonable number of final 
prospectuses delivered to purchasers under the Securities Act; and (v) for such 
period for which prospectuses are required to be delivered by dealers, provide 
such dealers with an adequate number of final prospectuses in order to permit 
the dealers to comply with their obligations under the Securities Act.  In all 
other regards, the Issuer agrees to comply with the requirements of the 
Securities Act in connection with any Underwritten Offering.

          (e)      RIGHT OF REDEMPTION.  The Issuer shall have the right to 
redeem the Unregistered Shares at a price equal to the average of the price as 
quoted for the Common Stock as set forth in the National Market of The Nasdaq 
Stock Market or, if the Common Stock shall be traded on any national or 
regional securities exchange, the latest bid price for the Common Stock, for 
the prior ten (10) trading days prior to the date the Demand is received.

     15.  NOTICES.  All notices and other communications hereunder shall be in 
writing and shall be deemed given when delivered in person, against written 
receipt therefor, or two days after being sent, by registered or certified 
mail, postage prepaid, return receipt requested, and, if to the Holder, at such 
address as is shown on the Warrant Register or as may otherwise may have been 
furnished to the Issuer in writing by the Holder and, if to the Issuer, at the 
Issuer's Office.

     16.  MISCELLANEOUS.  This Warrant and any term hereof may be changed, 
waived, discharged or terminated only by an instrument in writing signed by the 
party against which enforcement of such change, waiver, discharge or 
termination is sought.  This certificate is deemed to have been delivered in 
the State of Tennessee and shall be construed and enforced in accordance with 
and governed by the laws of such State.  The headings in this Warrant to 
Purchase Common Stock Certificate are for purposes of reference only, and shall 
not limit or otherwise affect any of the terms hereof.

     17.  EXPIRATION.  Unless as hereinafter provided, the right to exercise 
these Warrants shall terminate upon the expiration of the Exercise Period.

     IN WITNESS WHEREOF

                                            Response Oncology, Inc. 


DATED:  January 2, 1996               By:_______________________________
                                           Joseph T. Clark, President



                              PURCHASE FORM

                      TO: RESPONSE ONCOLOGY, INC. 

                                                Dated:_________________, 19__


     The undersigned hereby irrevocably elects to exercise the within Warrants, 
to the extent of purchasing __________ shares of Common Stock, and hereby makes 
payment of $______________ in payment of the actual Exercise Price thereof.

                    INSTRUCTIONS FOR REGISTRATION OF STOCK

Name:________________________________________________________________________
                  (Please typewrite or print in block letters)

Address:_____________________________________________________________________

Signature:___________________________________________________________________
          (Signature must conform in all respects to the name of the Holder as 
          set forth on the face of this Warrant.)



                                ASSIGNMENT FORM


     FOR VALUE RECEIVED, __________________________________ hereby sells, 
assigns and transfers unto

Name:_______________________________________________________________________
               (Please typewrite or print in block letters)

Address:____________________________________________________________________

the right to purchase shares of Common Stock represented by this Warrant to the 
extent of ___________________________________________ shares as to which such 
right is exercisable and does hereby irrevocably constitute and appoint 
_______________________________
Attorney-in-Fact, to transfer the same on the books of the Issuer with full 
power of substitution in the premises.

Dated:________________, 19__

Signature___________________________________________________________________
          (Signature must conform in all respects to the name of the Holder as 
          set forth on the face of this Warrant.)



                              Exhibit 7(a)(x)
                                    to
                         Stock Purchase Agreement

                           CERTIFICATE OF FACTS


     This Certificate is provided in connection with the transactions 
contemplated by the Stock Purchase Agreement dated as of December 20, 1995, by 
and among the Stockholders (the "Sellers") of Oncology Hematology Group of 
South Florida, P.A., a Florida professional association (the "Association"), 
South Florida Oncology Hematology Associates, P.A., a Florida professional 
association (the "New PA") and Response Oncology, Inc., a Tennessee corporation 
("Response"), pursuant to which Response is to acquire from the Sellers all of 
the outstanding capital stock of the Association and the new PA and Response 
are to enter into a Service Agreement (the "Transaction").

     The Association and Sellers acknowledge that the law firms of Baker, 
Donelson, Bearman & Caldwell, a professional corporation, and Zack, Sparber, 
Zosnitzky, Truxton, Spratt & Brooks, P.A. may rely on the certification of 
facts contained herein in connection with such firms' rendering their opinions 
concerning the Transaction to Response and to such lender, underwriter or other 
party as directed by Response.

     The undersigned person, in his own behalf and on behalf of all Sellers, 
and as President of the Association, does hereby certify the following:

     1.     The locations at which the Sellers and the Association conduct 
their practice and a description of the nature of such practice at each 
location is described on Exhibit "A" to this Certificate.  The Sellers and the 
Association do not conduct a practice or business at any locations other than 
those identified on Exhibit "A."
 
     2.     A list of all employment agreements and non-competition agreements 
and a description of the compensation arrangement with each employee whose 
services are billable is provided on Exhibit "B" to this Certificate.

     3.     The Sellers and any professional associated with or employed by the 
Association do not have any oral or written agreement or understanding with any 
organization or individual that provides health services or supplies other than 
those identified on Exhibit "C."

     4.     The Sellers and any professional associated with or employed by the 
Association do not have any endorsement arrangement with any manufacturer of 
drugs, biologicals or medical devices, including, but not limited to, surgical 
instruments or intraocular lenses other than those identified on Exhibit "D."

     5.     The Sellers and any professional associated with or employed by the 
Association do not have any oral or written agreements with professionals, or 
legal entities with which such professionals have an investment or compensation 
interest as defined by the Medicare and Medicaid Anti-Kickback Law (42 U.S.C. 
1320a-7(b)(b)), the Stark Self-Referral Law (42 U.S.C. 1395nn) or regulations 
promulgated thereunder and applicable state law, who may refer to or receive 
referrals from the Sellers or to professionals employed by the Association, 
other than those identified on Exhibit "E."

     6.     The Sellers and professionals associated with or employed by the 
Association are not members of a group referral service other than those 
identified on Exhibit "F."

     7.     The Sellers and professionals associated with or employed by the 
Association do not belong to a group purchasing organization other than those 
identified on Exhibit "G."

     8.     The Sellers and professionals associated with or employed by the 
Association are not parties to any recruitment or retention agreement with any 
hospital or health care provider for which the terms are ongoing other than 
those identified on Exhibit "H."

     9.     The Sellers and professionals associated with or employed by the 
Association do not allow waiver of Medicare/Medicaid or insurance co-payments 
and deductibles or their policy for waiver of Medicare/Medicaid or insurance 
co-payments and deductibles is stated on Exhibit "I."

     10.     The Sellers and professionals associated with or employed by the 
Association do not have any oral or written financial or cross-referral 
arrangements with any other provider of health care services not employed by 
the Association other than as identified on Exhibit "K."

     11.     The Sellers and professionals employed by the Association do not 
have an ownership or an investment interest in or any kind of compensation 
arrangement with any business that provides any of the following services other 
than as identified on Exhibit "L:"

          (a)     An ambulatory surgery center;

          (b)     Any agency, institution, facility or place which provides the 
following health care services:  burn unit, neonatal, intensive care unit, open 
heart surgery, cardiac catheterization, linear accelerator, positron emission 
tomography, psychiatric, obstetrical, maternity;

          (c)     A diagnostic laboratory;

          (d)     Any major medical equipment with value exceeding $1,000,000;

          (e)     Home health services (services to patients on an outpatient 
basis in either their regular or temporary place of residence);

          (f)     Hospital (in-patient or out-patient);

          (g)     Recuperation center;

          (h)     Nursing home;

          (i)     Convalescent home;

          (j)     Mental health hospital;

           (k)     Mental retardation institutional habilitation facility, 
including, but not limited to, intermediate care facilities for mental 
retardation and state-run institutions;

          (l)     Rehabilitation facility;

          (m)     Residential hospice;

          (n)     Mental health residential treatment facility;

          (o)     Home for the aged;

          (p)     Home health care agency;

          (q)     Alcohol and drug prevention treatment facility;

          (r)     Outpatient diagnostic center;

          (s)     Blood bank;

          (t)     Trauma center;

          (u)     X-ray equipment;

          (v)     Computerized axial topographers;

          (w)     Extracorporeal shock wave lithotripter;

          (x)     Magnetic resonance imagers;

          (y)     Physical therapy;

          (z)     Occupational therapy services;

          (aa)     Radiology or other diagnostic services;

          (bb)     Radiation therapy services;

          (cc)     Durable medical equipment;

          (dd)     Parenteral and enteral nutrients, equipment and supplies;

          (ee)     Prosthetics, orthotics and prosthetic devices.

     12.     The Sellers and professionals associated with or employed by the 
Association are in compliance with all health care laws and licensing laws of 
the states in which the Sellers and such professionals conduct their business 
and have not received or made payment or any remuneration whatsoever to induce 
or encourage the referrals of patients or the purchase of goods and/or services 
as prohibited under 42 U.S.C. 1320a-7b(b) or the regulations promulgated 
thereunder, or have not otherwise perpetrated any Medicare or Medicaid fraud or 
abuse or false claims nor have any fraud or abuse or false claims been alleged 
within the last five (5) years by any government agency.

     13.     The Sellers and all professionals associated with or employed by 
the Association have all permits and licenses required by all applicable laws; 
have made all regulatory filings necessary for the conduct of the Association's 
business; and are not in violation of said permitting or licensing 
requirements.

     14.     The Sellers and professionals associated with or employed by the 
Association have not in the past referred patients to Response or any physician 
or practitioner on Exhibit "M" or received referrals of patients from Response 
or any physician or practitioner on Exhibit "M", except as identified on 
Exhibit "M."

     15.     All agreements whereby Sellers or professionals associated with or 
employed by the Association provide or obtain professional services, management 
services, or use of space or equipment are identified on Exhibit "N" and each 
such agreement is in writing, for a term of at least one year and provide 
compensation or fees at fair market for such goods or services, except as 
identified on Exhibit "N."

     16.     The Sellers and professionals associated with or employed by the 
Association have not knowingly and willfully made or caused to be made any 
false statement or representation of a material fact in any application for any 
benefit or payment under the Medicare or Medicaid programs.

     IN WITNESS WHEREOF, the undersigned has executed and delivered this 
Certificate as of January 2, 1996.



                                   ONCOLOGY HEMATOLOGY GROUP OF
                                   SOUTH FLORIDA, P.A.

                                   By: _________________________________
                                   Title: _______________________________



                                   ____________________________________
                                   Leonard E. Kalman, M.D. 



                               Exhibit A

                           Office Locations



                               Exhibit B

                     List of Employment Agreements



                               Exhibit C

         Agreements with Health Services or Supplies Providers



                               Exhibit D

                      Endorsement Arrangements



                               Exhibit E

                    Agreements with Professionals



                               Exhibit F

                       Group Referral Services



                               Exhibit G

                   Group Purchasing Organizations



                               Exhibit H

                        Recruitment Agreements



                               Exhibit I

             Waiver Policy for Co-Payments and Deductibles



                               Exhibit K

    Financial Arrangements with Health Care Professionals Not Employed



                               Exhibit L

                         Investment Interests



                               Exhibit M

                           List of Referrals



                               Exhibit N

                          Material Agreements